University of Memphis

University of Memphis Digital Commons
Electronic Theses and Dissertations
4-18-2012

Comparison of a Traditional and Modified Daniel Fast on Blood
Lipids, Lipid Peroxidation, and Inflammation
Rick John Alleman Jr.

Follow this and additional works at: https://digitalcommons.memphis.edu/etd

Recommended Citation
Alleman, Rick John Jr., "Comparison of a Traditional and Modified Daniel Fast on Blood Lipids, Lipid
Peroxidation, and Inflammation" (2012). Electronic Theses and Dissertations. 465.
https://digitalcommons.memphis.edu/etd/465

This Thesis is brought to you for free and open access by University of Memphis Digital Commons. It has been
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of University of
Memphis Digital Commons. For more information, please contact khggerty@memphis.edu.

COMPARISON OF A TRADITIONAL AND MODIFIED DANIEL FAST ON BLOOD
LIPIDS, LIPID PEROXIDATION, AND INFLAMMATION
by
Rick J. Alleman Jr., BA

A Thesis
Submitted in Partial Fulfillment of the
Requirements for the Degree of
Master of Science

Major: Health and Sport Sciences

The University of Memphis
May 2012

ABSTRACT
Alleman Jr, Rick John. EXSS. The University of Memphis. 05/2012.
Comparison of a Traditional and Modified Daniel Fast on Blood Lipids, Lipid
Peroxidation, and Inflammation. Major Professor: Dr. Richard Bloomer
Dietary modification involving the removal of animal products, protein, and
processed foods results in rapid and significant improvements in multiple health markers.
We compared the impact of two restriction models on biomarkers of inflammation,
oxidative stress, and cardiovascular health over a 21-day intervention. One model was a
stringent vegan diet; the other was identical but included ~30g/d of additional protein in
the form of meat and dairy. Compared to baseline, both models resulted in similar and
significant improvements in blood lipids, as well as a reduction in inflammation.
Modification of dietary intake may improve risk factors for cardiovascular disease.
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Introduction
For decades scientists have been investigating the effects of dietary intake on
certain parameters of human health. Further advancements in technology have allowed
for a more intuitive approach to analyzing the effects of nutrient intake on specific healthrelated biomarkers [1-3]. Fasting is a period of abstinence from some or all food, drink,
or both, usually for a pre-determined period of time (reviewed in [4]). Fasting plans that
are frequently studied and presented in the scientific literature include caloric restriction
(CR) [5], alternate day fasting (ADF) [6], and dietary restriction (DR) [7].
Individuals who partake in CR plans strive to reduce their overall caloric intake
on a daily basis (usually by 20-40% of daily energy requirements), while those partaking
in ADF diets will alternate days of ad libitum feeding with days in which little to no
calories are consumed. Dietary restriction is another plan that is characterized by the
reduction or abstinence of certain components of the diet, such as amino acids or animal
products. The religiously-motivated Daniel Fast, a stringent vegan diet that has been
investigated recently and noted to result in multiple health-related benefits [8, 9], falls
into this category of DR.
Many people partake in these fasting regimens in order to meet weight loss goals
or to improve certain biomarkers of health, while others become involved for spiritual
purposes. Prior investigations involving CR, ADF, and DR have been met with favorable
results. Specifically, the benefits associated with CR, without malnutrition, include
improved cardiovascular health, increased insulin sensitivity and glucose regulation,
decreased oxidative damage, favorable changes in blood lipids, and reduced production
of inflammatory mediators (reviewed in [10, 11]). It is postulated that these health-
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related benefits are responsible for the life-extending effects of CR, which has been
demonstrated in rodents [12] and other animals [13]. Similarly, studies that involve ADF
in rodents have reproduced some of the same favorable effects as CR with regards to
increasing lifespan, lowering cardiovascular disease (CVD) risk, as well as improving
variables related to diabetes (reviewed in [14]). A CR and ADF diet produces similar
reductions in total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and
triglycerides (TAG) [15]. The Daniel Fast has also been reported to reduce TC and LDLC [8]. Lipid disorders have been identified as independent risk factors for CVD [16] and
intervention studies have shown that treating these abnormalities decreases the risk for
cardiovascular events [17]. Therefore, improving the blood lipid panel appears important
for overall health.
Diets that reduce caloric intake generally reduce markers of oxidative stress such
as, malondialdehyde (MDA) and hydrogen peroxide (H2O2) [18], which may be due to a
decrease in the production of reactive oxygen and nitrogen species (RONS) such as
superoxide (O2•-). Similarly, ADF reduces markers of oxidative stress, as measured by
protein carbonyls, nitrotyrosine, and 8-isoprostanes [15]. The Daniel Fast has also been
reported to result in a lowering in oxidative stress biomarkers [9].
In addition to attenuated oxidative stress, CR has been shown to reduce
inflammation, evidenced by a reduction in circulating levels of leukocytes and other
inflammatory markers such as tumor necrosis factor alpha (TNF-α) and C-reactive
protein CRP [19, 20]. While data are conflicting for the effects of ADF on inflammation,
the literature indicates no effect of ADF on IL-6 and TNF- α [14] and little to no effect on
CRP [15]. However, 8-weeks of ADF in overweight adults with moderate asthma
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significantly reduces TNF-α [15]. With regards to the Daniel Fast, reductions in CRP
that approached statistical significance have been reported [8]. Reducing systemic
inflammation appears important, considering that increased inflammation and oxidative
stress may be an underlying mechanism in the pathophysiology of aging and many agerelated illnesses/diseases [21-24].
Similar to the above mentioned plans, a specific form of DR involving methionine
restriction has been shown to be inversely correlated with maximum lifespan potential in
rats [25]. While there is still much to be understood with regards to methionine
restriction and longevity in humans, vegetarian diets tend to be low in methionine content
and studies have consistently demonstrated improvements in blood lipids and decreased
age-associated oxidative stress (reviewed in [26]). Additionally, investigations have
noted significantly lower CRP in vegetarians when compared to age-matched nonvegetarians [27, 28].
Considered a variant of veganism, the Daniel Fast has demonstrated favorable
outcomes on blood lipids [8]. Specifically, a 21-day Daniel Fast has indicated significant
reductions in TC and LDL-C, but also resulted in a decrease in high-density lipoprotein
cholesterol (HDL-C). Additional work involving a 21-day Daniel Fast has noted
reductions in the TC/HDL-C ratio and LDL-C/HDL-C ratio, with similar effects on the
other blood lipids (unpublished data). While vegetarian diets appear to have little effect
on oxidative stress markers in younger women (age: 20-40 years) [29], a 21-day Daniel
Fast in men and women (age 35 ± 1 years) has demonstrated decreases in both MDA and
H2O2 [9]. With regards to antioxidant status, Trolox Equivalent Antioxidant Capacity
(TEAC) has been reported to significantly increase following a 21-day Daniel Fast, with
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no changes in the oxygen radical absorbance capacity (ORAC) [9]. The noted downside
of this form of DR is that HDL-C is reduced [8]. Maintaining HDL-C would be
advantageous due to the associated atheroprotective benefits [30].
Although reductions in HDL-C is common during low-fat vegetarian diets,
without being associated with poor cardiovascular health (reviewed in [31]), efforts to
maintain HDL-C during a DR period should be considered. One possible plan is to
consider the inclusion of small amounts of animal protein to the diet during a traditional
Daniel Fast plan. While studies indicate that meat consumption is directly related to an
increased risk for disease [32], the quality of the meat (i.e. lean meat) is more important
when considering the effects on blood lipids and disease [33-35]. Diets that include
moderate consumption of lean beef and chicken [36, 37], as well as lean fish [43], are
associated with modest increases in HDL-C. Alternatively, removing meat from the diet
tends to lower HDL-C while having a greater effect on reducing TC and LDL-C [38]. It
appears as though the protein from meat is not what causes an increase in oxidative stress
and inflammation [39]. Rather, the type of fat appears to be more important when
considering oxidative stress and inflammation, with exacerbated responses from
increasing amounts of saturated fatty acids (SFA) [40].
Using a case study approach, we have recently noted that minimal consumption of
low-fat meat (poultry and fish) and dairy (skim milk) allows for a similar, albeit not as
striking, reductions in TC and LDL-C as compared to the traditional Daniel Fast, with
little change in HDL-C. Moreover, the TC/HDL-C ratio was better with the modified
plan compared to the traditional plan. Hence, further study with this modified plan needs
to be considered, with direct comparison being made to the traditional Daniel Fast plan in
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regards to blood lipids, as well as biomarkers of oxidative stress and inflammation. This
was the purpose of the present investigation.
Methods
Subjects
Twenty-nine healthy men and women between the ages of 18 and 75 years were
recruited to participate. Subjects were not current smokers, and did not have a history of
controlled cardiovascular or metabolic problems (e.g., high blood pressure, diabetes).
Subjects were not required to engage in any strenuous tasks during the course of their
participation. They were instructed to simply alter their dietary intake in favor of more
healthy food choices.
Health history, medication and dietary supplement usage, and physical activity
questionnaires were completed by all subjects and reviewed in detail by the study
coordinator (with consultation with the PI as needed) to determine eligibility. Prior to
participation, each subject was informed of all procedures, potential risks, and benefits
associated with the study through both verbal and written form in accordance with the
procedures approved by the University Institutional Review Board for Human Subjects
Research. All subjects signed an informed consent form prior to being admitted as a
subject.
Study Timeline
Week 0

Initial screening: Paperwork and diet instructions/logs; plan assignment

Week 1

Complete 7 day diet record and prepare for Fast

Week 2-4

Day 1: Fasting blood sample, measurements; Start Fast (for 3 weeks)
Week 4: Complete 7 day diet record
End Week 4: Fasting blood sample, measurements, post-fast questionnaire
5

Daniel Fast and Modified Daniel Fast
Subjects were assigned to either the traditional Daniel Fast (vegan diet) or the
Daniel Fast inclusive of one serving per day of lean meat (3 ounces of chicken, fish, beef,
pork, or turkey) and skim milk (8 ounces). Following all baseline assessments and the
initial week of dietary recording, subjects underwent their Daniel Fast assignment for 3
weeks. While numerous websites are available with information and recipes related to
this fast, subjects were provided an outline of the foods that are routinely allowed, as well
as commonly consumed foods that are not allowed. For simplicity sake, subjects were
informed that the diet essentially consists of fruits and vegetables, nuts, seeds, legumes,
vegetable, oil, and grains. In addition, no additives, preservatives, flavoring, caffeine, or
alcohol were allowed. Subjects were allowed caffeinated coffee and tea, as well as water,
to drink. This applied to subjects in both plans (traditional and modified). Those
subjects assigned to the traditional Daniel Fast plan were not allowed any animal
products, while subjects assigned to the modified Daniel Fast plan were required to
consume one serving per day of lean meat (3 ounces) and one serving per day of skim
milk (8 ounces). Subjects were exposed to food models to have a better understanding of
portion sizes.
Lab Visits
During the initial visit to the lab, subjects completed the informed consent form,
health, and physical activity questionnaires. They were also informed of their assigned
condition (traditional or modified Daniel Fast plan), and received study instructions and a
study schedule. During the other lab visits (end of weeks 1 and 4), all assessments were
performed. Heart rate (via palpation) and blood pressure (via cuff and stethoscope) was
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recorded following a 10 minute period of quiet rest. A blood sample was then taken from
subjects, as described below. Subjects’ height, weight, and circumference measures were
recorded. Subjects then had a scan performed to determine their body composition (via
dual energy x-ray absorptiometry [DEXA]), as described below.
Blood Collection and Biochemistry
Venous blood samples (20mL; 4 teaspoons) were taken from subjects via needle
and Vacutainer® by a trained phlebotomist. Blood samples were collected in a rested
and fasted state at the end of week 1 (before beginning the fast) and week 4. Following
collection, blood collected in tubes with no additives was allowed to clot at room
temperature for 30 minutes and then separated to serum by centrifugation at 1500g for 15
minutes at 4°C. Samples were sent to Laboratory Corporation of America (LabCorp) for
a lipid panel and CRP evaluation. Blood collected in tubes containing
ethylenediaminetetraacetic acid (EDTA) was immediately separated to plasma by
centrifugation at 1500g for 15 minutes at 4°C. Plasma was stored and analyzed for
MDA. The lipid panel was determined using enzymatic procedures (Roche/Hitachi
Modular). C-reactive protein was determined using a high-sensitivity, particle-enhanced
turbidimetric immunoassay (Roche Integra 800). Malondialdehyde was analyzed in
plasma following the procedures of Jentzsch et al [41] using reagents purchased from
Northwest Life Science Specialties (Vancouver, WA). Specifically, 75µL of plasma was
added to microcentrifuge reaction tubes and 75µL of 1M phosphoric acid and 75µL of 2thiobarbituric acid reagent was added to each reaction tube and mixed thoroughly.
Samples and reagents were incubated for 60 minutes at 60°C. Following incubation,
tubes were removed, and the reaction mixture was transferred to a microplate. The
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absorbance was read using a spectrophotometer at both 535 and 572nm to correct for
baseline absorption. Malondialdehyde equivalents were calculated using the difference
in absorption at the two wavelengths. Quantification was performed with a calibration
curve using tetramethoxypropane in a stabilizing buffer. The detection limit for MDA, as
per the manufacturer, is 0.1µM.
Dual energy x-ray absorptiometry (DEXA)
Although not a primary outcome measure in the present study, body composition
was determined via DEXA. After the participant removed all extraneous metal objects,
he or she was placed onto the QDR 4500W table in the supine position within the
designated whole body scan area which is defined on the table mattress. The upper
extremities were positioned palm down beside the thighs and care was taken to assure
that the arms did not come in contact with the thigh; the feet of the participant were taped
together. The DEXA scan was performed by a certified technician. Total and regional
body fat percentages were computed in addition to fat and fat-free mass.
Dietary Records and Activity
During the initial lab visit a full explanation of dietary recording was provided to
subjects, along with data collection forms. An overview of study procedures was also
provided. All subjects were instructed to maintain their normal diet during week one of
the study (prior to beginning the fast) and to record on data forms all food and drink
consumed. During week 2 of the study, subjects began the Daniel Fast (traditional or
modified) and were asked to record on data forms all food and drink consumed during
week 4 of the study (the final week of the fast). Nutritional records from subjects before
and during the fast period were analyzed for total calories, protein, carbohydrate, fat, and
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a variety of micronutrients (Food Processor SQL, version 9.9, ESHA Research, Salem,
OR). Subjects were instructed to maintain their normal physical activity habits during the
entire study period. Subjects were given specific instructions regarding abstinence of
alcohol consumption, in addition to the avoidance of strenuous exercise during the 48
hours immediately preceding the assessment days.
Compliance, Mood, Vitality, and Satiety
As an assessment of compliance, mood, vitality, and satiety, subjects were asked
to complete a questionnaire related to their experience on the Daniel Fast (Appendix B).
These data were based solely on subjects’ self-report.
Statistical Analysis
Biochemical data were analyzed using a 2 (plan) x 2 (time) analysis of variance
(ANOVA). Tukey post hoc tests were used as needed. Dietary data, anthropometrics,
compliance, mood, vitality, and satiety data were analyzed using a one-way ANOVA.
All analyses were performed using JMP statistical software (version 4.0.3, SAS Institute,
Cary, NC). Statistical significance was set at P ≤ 0.05. The data are presented as mean ±
SEM.
Results
Twenty-nine subjects completed the study, 13 in the modified Daniel Fast diet
and 16 in the traditional Daniel Fast diet. Subjects’ descriptive characteristics are
presented in Table 1. The main variables of interest were blood lipids, MDA, and CRP.
We hypothesized that these variables would decrease to a similar extent between the two
groups, with a greater reduction in HDL-C for subjects in the traditional Daniel Fast plan
compared to the modified plan. In short, we observed no significant difference between
the two dietary regimens on any of the main outcome variables. Although not significant,
9

there was a greater reduction in HDL-C in the traditional Daniel Fast group (13.3%)
compared to the modified group (7.6%). A summary of our results are presented in Table
2.
Compliance, Mood, Vitality, and Satiety
All subjects completed the diet intervention as well as the pre and post
assessments. Compliance was similar between groups (traditional: 96.0 ± 0.94% vs.
modified: 91.4 ± 3.1%; p = 0.13). On a scale from 0-10, subjects rated their mood,
vitality, and satiety during the diet. There were no condition x time interactions for the
following variables (p > 0.05); “mental outlook” (traditional: 8.8 ± 0.3 vs. modified: 8.8
± 0.3), “physical health and vitality” (traditional: 8.3 ± 0.5 vs. modified: 8.4 ± 0.5), and
“feeling of satiety” (traditional: 8.8 ± 0.3 vs. modified: 8.3 ± 0.6). In both groups,
“mental outlook” (p = 0.03) and “physical health and vitality” (p = 0.006) increased from
pre to post (“mental outlook”: 8.1 ± 0.5 to 8.8 ± 0.3 and 7.9 ± 0.3 to 8.8 ± 0.3 in the
traditional and modified groups respectively, “physical health and vitality”: 7.4 ± 0.4 to
8.3 ± 0.5 and 6.6 ± 0.5 to 8.4 ± 0.5 in the traditional and modified groups respectively).
Body weight and composition
No condition x time interactions were noted for body weight (p = 0.98), total
body fat percentage (p = 0.96), or trunk body fat percentage (p = 0.94). Data are
presented in Table 1. There was no significant difference in body weight from pre to post
(p = 0.68) in the traditional group (pre: 81.7 ± 4.8 kg vs. post: 79.3 ± 4.9 kg) or in the
modified group (pre 74.5 ± 6.1 kg vs. post: 72.4 ± 5.7 kg). Total body fat percentage was
not significantly different (p = 0.92) from pre to post in the traditional group (pre: 35.7%
± 2.4 vs. post: 35.5 ± 2.5%) or in the modified group (pre: 33.8 ± 3.5% vs. post: 33.4 ±
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3.6%). Similarly, trunk body fat percentage was not significantly different (p = 0.94)
from pre to post in the traditional group (pre: 36.5 ± 2.5% vs. post: 36.2 ± 2.6%) or in the
modified group (pre: 32.8 ± 3.7% vs. post: 32.0 ± 3.7%). Neither group experienced
significant changes in fat mass (p = 0.80) or fat-free mass (p = 0.70) from pre to post.
Blood Lipids, Malondialdehyde, and C-Reactive Protein
No interactions, condition, or time effects were noted for TAG, LDL-C, HDL-C,
VLDL-C, TC:HDL-C ratio, LDL-C:HDL-C ratio, or CRP (p > 0.05). Total cholesterol
significantly decreased (p = 0.02) to a similar extent in the traditional group (16.7%) and
modified group (14.2%) but no interactions or condition effects were noted (p > 0.05). A
condition effect was noted for MDA (p = 0.03), with higher levels in the traditional
group, but no significant interactions or time effects were noted (p > 0.05). A summary
of our main outcome variables can be viewed in Table 2.
Dietary Data
Dietary Data are presented in Table 3. Intake between the groups was
significantly different for grams of protein (p = 0.009), percentage of protein (p = 0.001),
selenium (p = 0.007), and calcium (p < 0.01). Compared to the traditional group, the
modified group consumed significantly more protein (p = 0.04), percentage of protein (p
= 0.02), and Vitamin D (p = 0.04). During the diet, both groups consumed less
kilocalories (p = 0.0002), grams of protein (p = 0.002), grams of carbohydrate (p < 0.01),
sugar (p = 0.0006), grams of total fat (p < 0.0001), percentage of fat (p = 0.006), SFA (p
< 0.0001), cholesterol (p < 0.0001), selenium (p < 0.01), and calcium (p < 0.0001), while
consuming more grams of fiber (p = 0.0008), grams of soluble fiber (p = 0.01),
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percentage of carbohydrate (p = 0.018), Vitamin A (p < 0.001), and Vitamin C (p =
0.0005).
Discussion
The results of the study indicate that there is no difference between a traditional
Daniel Fast and a modified Daniel Fast, on selected biomarkers of health. We
hypothesized that the diets would yield similar decreases in MDA, CRP, TC and LDL-C.
In addition, we hypothesized that the traditional Daniel Fast group would experience a
greater reduction in HDL-C. Although slightly different, both diets had similar effects
statistically on all of the main outcome variables; blood lipids, MDA, and CRP.
Prior work with the Daniel Fast, along with data from the present investigation,
indicates that a Daniel Fast dietary regimen is beneficial for cardiovascular and metabolic
health [8, 9]. Our data indicate that these benefits are maintained when small quantities
of animal products are added to a traditional Daniel Fast diet. In addition to the
cardiovascular and metabolic benefits observed over a short period of time (21 days), the
Daniel Fast has been shown to be well tolerated, with greater than 95% compliance [8, 9].
However, we have noted that the restriction of animal products makes the diet
challenging and less appealing to many individuals. While compliance was similar
between the diets during the present investigation, further research is still needed to
compare long-term compliance and health benefits. Our goal in the present study was to
determine if the addition of animal products to a traditional Daniel Fast would produce
similar results as seen in the past, when followed for the same duration of study (3
weeks).
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Total cholesterol significantly decreased in both groups: 16.7% in the traditional
group and 14.2% in the modified group. Both diets demonstrated a similar nonsignificant decrease in LDL-C, 17.4% and 18.2% in the traditional and modified groups,
respectively. Moreover, both diets resulted in similar non-significant reductions in
VLDL-C, TAG, LDL-C:HDL-C ratio, and TC:HDL-C ratio, which is similar to what has
been observed in healthy men undergoing a vegetarian diet or a vegetarian plus lean meat
diet [42]. We hypothesized that the traditional Daniel Fast group would experience a
greater reduction in HDL-C, which is common when undergoing a vegan based diet [31].
Furthermore, low cholesterol diets that include moderate consumption of lean meat have
shown modest increases in HDL-C in healthy [42] and hypercholesterolemic [36, 43]
subject populations. It appears as though lean meat may not be responsible for the rise in
cardiovascular related diseases; rather, additives, preservatives, and the SFA associated
with animal products and fast food may be the culprit.
In the present investigation, there was a non-significant decrease in HDL-C;
13.3% in the traditional group and 7.6% in the modified group. Earlier work with the
traditional Daniel Fast demonstrated a significant reduction in HDL-C (14.5%) after 21
days of the diet [8]. As mentioned previously, adding small quantities of lean red or
white meat to a cholesterol lowering diet helps maintain HDL-C in hypercholesterolemic
men and women [36, 43]. Likewise, significant increases in HDL-C, and the LDLC:HDL-C ratio have been observed in healthy middle aged males undergoing a
combination of a vegetarian diet and 150 g/day of lean meat for one month [42]. While
the results indicate no difference of statistical significance between the diets, when
adding a small amount of lean meat (3 ounces) and skim milk (8 ounces) to an otherwise
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strict vegan diet, less of a decrease in HDL-C is observed. Although not of statistical
significance, the difference may have clinical relevance, in particular if the plan was
carried out over a longer period of time and the changes were of greater magnitude. It is
also possible that increasing the sample size may assist in uncovering findings of
statistical significance.
Some studies suggest that the omega-6/omega-3 fatty acid ratio is important when
considering changes in HDL-C. In healthy young adult males, a 3% increase in HDL-C
was observed after three weeks of a low SFA diet (9% of total energy) with increased
intake of omega-3 polyunsaturated fatty acids (PUFA) (5 g/day) [44]. In another study,
Rajaram et al compared the effects of two diets rich in omega-3 PUFA and low in SFA (<
10% SFA) in mildy hyperlipidemic men and women, one from walnuts (42.5 g, 6
days/week) and the other from salmon (4 ounces raw, 2 twice/week) [37]. After four
weeks, the fish diet resulted in a significantly greater increase in HDL-C. However, a
more favorable change in the LDL-C:HDL-C ratio was observed in the walnut diet. In
the present investigation, the modified Daniel Fast group experienced a slightly smaller
decrease in HDL-C compared to the traditional diet. Noteworthy, was the change in the
LDL-C:HDL-C ratio. Although not significant, a 15.7% decrease was observed in the
modified group, compared to a 5.8% decrease in the traditional diet. The omega6/omega-3 fatty acid ratio in the traditional and modified groups was 12.3 and 7.4
respectively. With careful review of the changes in blood lipids, perhaps the modified
group benefited from the combination of omega-3 PUFA from plants and meat.
Nonetheless, a favorable change in the ratio is more important when considering the
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cholesterol carrying properties of the different lipoprotein particles, and may have clinical
relevance.
In contrast to previous work with the Daniel Fast [9], in the present study MDA
was not significantly impacted by either diet. Baseline MDA was significantly higher in
the traditional Daniel Fast group, whereas the modified group had relatively low baseline
levels of MDA (0.92 ± 0.14 µmol∙L-1 vs. 0.62 ± 0.03 µmol∙L-1, respectively). While there
were no significant differences between the groups from pre to post, a 16% decrease in
MDA was observed in the traditional group whereas a 3.1% increase in MDA was
observed in the modified group. Other studies have also shown that adding lean meat to
the diet does not negatively impact biomarkers of oxidative stress. In a cohort study
including healthy lacto-ovo-vegetarians and omnivores, MDA was not different across
the groups [29]. When 215 g/day of lean red meat was used to replace carbohydrate rich
foods in middle aged men and women with high blood pressure, plasma F2-isoprostanes
did not change [39]. While it appears that small amounts of lean meat/protein does not
negatively impact biomarkers of oxidative stress, diets that incorporate increasing
amounts of fruit and vegetable intake have demonstrated favorable changes in oxidative
stress biomarkers. Furthermore, urinary excretion of 8-isoprostane F2α was significantly
decreased in healthy women undergoing a high fruit and vegetable diet for eight weeks
(9.2 servings of fruit and vegetables per day) [45]. Similarly, 8-isoprostane F2α has been
shown to significantly decrease after only 14 days of a dietary intervention that increased
fruit and vegetable intake to 12 servings per day. Interestingly, the authors noted no
difference in urine concentrations of MDA [46]. Isoprostanes and MDA are the more
prominent biomarkers of lipid peroxidation. However, other relatively stable end
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products can be measured such as lipid hydroperoxides, α,β-unsaturated aldehydes,
conjugated dienes, oxidized low-density lipoprotein, and 4-hydroxy-2-nonenal. In the
present investigation, even though MDA did not change, it is possible that other
biomarkers of oxidative stress were influenced. Using MDA as the exclusive biomarker
of oxidative stress is a limitation of our study.
The ongoing regulation of the production and quenching of free radicals is an
essential process in biological redox signaling. Dysfunction in the body’s ability to
regulate RONS production has been implicated in the pathogenesis of many age related
diseases; atherosclerosis, type II diabetes mellitus, and Alzheimer’s disease to name a
few [47]. The inability to scavenge increased RONS production has also been implicated
in the early onset of systemic inflammation [48]. Dietary intake can affect the
inflammatory response in the body, and this response has been linked to oxidative stress,
insulin resistance, obesity, and CVD [49]. C-reactive protein in particular has been
shown to be a reliable marker of systemic inflammation during the development of CVD
[50], and any effect on this biomarker by the two diets are noteworthy.
There were no observed differences in CRP between the two diets. In a
population with already low CRP levels (< 1.5 mg/L), the two diets demonstrated a trend
for reducing CRP, both producing greater than 40% reductions. Although not statistically
significant, this change may be clinically meaningful, especially due to the fact that the
American Heart Association has identified CRP as an independent predictor for CVD risk
[51].
Both groups in the present investigation increased dietary antioxidant intake,
specifically Vitamin C and Vitamin A. A crossover study in healthy middle aged men
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and women (~60 years old) undergoing a high-total antioxidant diet demonstrated
significant decreases in CRP compared to a low-total antioxidant diet. In addition, no
changes were observed in MDA following the dietary intervention [52]. The changes
observed in the aforementioned study were similar to our findings in regards to the
changes in CRP and MDA, indicating an improvement in systemic inflammation without
changes in markers of oxidative stress. An investigation by Katcher et al studied the
effects of a hypocaloric diet that included whole grains, fruits, vegetables, and small
quantities of lean meat and low-fat dairy products in obese individuals with metabolic
syndrome. Sharing many of the same characteristics as a modified Daniel Fast, the
results of the study indicated a significantly greater reduction in CRP when including
whole grains compared to refined grains [53]. Others have shown SFA be the most
important variable contributing to CRP in healthy young adults [54]. This could explain
a portion of the benefits observed in the present investigation, owing to the fact that both
groups reduced dietary SFA to less than 8 grams during the intervention.
Recently, large cohort studies have delineated a relationship between red meat
consumption, metabolic syndrome [55] and increased mortality [56]. Included in these
cohort studies are processed meats, organ meats, and red meats. Indeed, the consumption
of processed meats have been associated with coronary heart disease and diabetes,
however, this relationship does not hold true for red meat alone (i.e. beef, hamburgers,
lamb, pork, or game) [57]. Based on our investigation, as well as a review of the relevant
literature, the effects of adding a moderate amount of lean meat (i.e. red meat, white
meat, and/or fish) to a strict vegan diet produces similar results in health biomarkers as a
strict vegan diet.
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Conclusion
In conclusion, our results indicate that the addition of lean meat to a traditional
Daniel Fast appears as beneficial as the vegan based Daniel Fast, if not yielding slightly
more favorable results with regard to changes in HDL-C and certain lipid panel ratios.
Both diets produced similar changes in all measured outcome variables. While these
findings are interesting, future research is needed to assess the long-term health benefits
of this plan, as well as the long-term compliance of individuals following this approach
within a free living environment.
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APPENDIX A
TABLES
Table 1. Descriptive characteristics of men and women following a traditional and
modified Daniel Fast for three weeks
Variable
Time

Traditional

Modified

Pre

Post

Pre

Post

Number
Age (yrs)
Height (cm)

16
42.4 ± 4.1
165.8 ± 2.0

16
42.4 ± 4.1
165.9 ± 2.0

13
41.7 ± 4.0
166.8 ± 2.2

13
41.7 ± 4.0
166.8 ± 2.2

Weight (kg)
BMI (kg∙m-2)

81.7 ± 4.8
29.7 ± 1.6

79.3 ± 4.9
28.8 ± 1.6

74.5 ± 6.1
26.6 ± 1.8

72.4 ± 5.7
25.9 ± 1.7

Waist (cm)

90.2 ± 3.8

87.8 ± 4.0

82.6 ± 5.2

80.9 ± 4.9

Hip (cm)
Waist:Hip
DEXA Total (%)
Fat-Free Mass (kg)
Fat Mass (kg)
DEXA Trunk (%)
Heart Rate (bpm)
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Aerobic Exercise (hrs∙wk-1)
Years Aerobic Exercise
Anaerobic Exercise (hrs∙wk-1)
Years Anaerobic Exercise

109.8 ± 3.1
0.82 ± 0.03
35.7 ± 2.4
52.1 ± 3.3
29.6 ± 2.9
36.5 ± 2.5
69.0 ± 2.2
115.1 ± 5.0
72.2 ± 3.3
3.9 ± 1.0
9.1 ± 3.2
0.9 ± 0.3
2.0 ± 0.8

107.6 ± 3.1
0.82 ± 0.03
35.5 ± 2.5
50.6 ± 3.3
28.6 ± 2.9
36.2 ± 2.6
65.6 ± 2.1
111.9 ± 5.2
71.9 ± 4.3
NA
NA
NA
NA

106.0 ± 3.0
0.77 ± 0.03
33.8 ± 3.5
49.3 ± 4.1
26.4 ± 4.0
32.8 ± 3.7
69.3 ± 2.5
105.6 ± 3.9
68.9 ± 2.8
2.3 ± 0.4
7.6 ± 2.3
0.9 ± 0.4
4.3 ± 1.9

104.3 ± 2.9
0.77 ± 0.03
33.4 ± 3.6
48.2 ± 3.9
25.4 ± 3.9
32.0 ± 3.7
68.3 ± 2.6
106.7 ± 4.2
64.1 ± 2.7
NA
NA
NA
NA

Values are presented as mean ± SEM.
No statistically significant differences noted (p > 0.05)
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Table 2. Blood lipid, MDA, and CRP data of men and women following a traditional
and modified Daniel Fast for three weeks
Variable
Time

Traditional

Modified

Pre

Post

Pre

Post

Cholesterol (mg·dL-1)

186.75 ± 13.48

155.63 ± 9.74*

180.69 ± 11.82

155.08 ± 11.86*

Triglycerides (mg·dL-1)

101.00 ± 10.93

78.69 ± 6.65

89.54 ± 8.91

79.31 ± 10.03

HDL-C (mg·dL-1)

56.31 ± 3.80

48.81 ± 3.38

58.62 ± 4.22

54.15 ± 3.65

VLDL-C (mg·dL-1)

20.19 ± 2.17

15.75 ± 1.31

18.08 ± 1.78

15.85 ± 2.00

110.25 ± 12.08

91.06 ± 8.42

104.00 ± 10.92

85.08 ± 9.85

LDL-C:HDL-C

2.08 ± 0.22

1.96 ± 0.19

1.97 ± 0.31

1.66 ± 0.23

TC:HDL-C

3.47 ± 0.25

3.32 ± 0.22

3.28 ± 0.34

2.97 ± 0.27

0.92 ± 0.14**

0.76 ± 0.08**

0.62 ± 0.03**

0.64 ± 0.05**

1.36 ± 0.26

0.81 ± 0.24

1.45 ± 0.50

0.85 ± 0.28

LDL-C (mg·dL-1)

MDA (µmol∙L-1)
CRP (mg∙L-1)

Values are presented as mean ± SEM.
* Indicates significant difference from pre to post (p = 0.02)
** Indicates significant difference between groups (p = 0.03)
No other statistically significant difference noted (p > 0.05)
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Table 3. Dietary data of men and women following a traditional and modified
Daniel Fast for three weeks
Variable

Traditional

Modified

Time
Pre
Post
Pre
Kilocalories
2070.3 ± 211.9 1141.1 ± 74.2* 1977.5 ± 186.7
Protein (g)***
69.8 ± 5.3**
35.9 ± 2.7*
73.4 ± 9.7**
Protein (%)***
13.9 ± 0.5**
12.6 ± 0.7
15.1 ± 1.6**
Carbohydrate (g)
256.6 ± 24.5
176.3 ± 13.0*
264.8 ± 31.7
Carbohydrate (%)
50.3 ± 2.0
62.3 ± 2.5
52.7 ± 2.3
Fiber (g)
19.9 ± 2.0
26.8 ± 2.0*
18.5 ± 2.0
Fiber-soluble (g)
0.9 ± 0.35
2.4 ± 0.42*
1.3 ± 0.6
Sugar (g)
86.6 ± 9.7
53.9 ± 6.5*
110.4 ± 18.5
Fat (g)
84.2 ± 11.5
37.0 ± 3.9*
68.5 ± 8.0
Fat (%)
35.6 ± 1.7
28.5 ± 2.2*
31.5 ± 2.5
SFA (g)
25.9 ± 3.8
6.4 ± 0.7*
20.2 ± 2.6
Monounsaturated
Fat (g)
21.3 ± 4.8
11.3 ± 1.8
15.3 ± 2.6
PUFA (g)
9.7 ± 1.9
6.4 ± 0.8
9.2 ± 1.6
Trans Fat (g)
3.1 ± 1.9
0.1 ± 0.1
1.7 ± 0.6
Omega 3 (g)
0.6 ± 0.1
0.4 ± 0.1
0.5 ± 0.2
Omega 6 (g)
7.8 ± 1.9
4.9 ± 0.7
5.9 ± 1.0
Cholesterol (mg)
258.0 ± 38.0
12.3 ± 5.0*
219.0 ± 25.3
Vitamin C (mg)
44.9 ± 5.1
112.1 ± 21.7*
59.0 ± 12.0
Vitamin E (mg)
6.1 ± 1.2
5.4 ± 0.9
4.9 ± 0.9
Vitamin A (RE)
208.8 ± 78.7
781.1 ± 155.8*
204.1 ± 49.5
Selenium (µg)
40.7 ± 5.2**
21.4 ± 2.8*
52.4 ± 8.5**
Calcium (mg)
583.6 ± 91.8**
251.4 ± 18.7* 700.2 ± 46.1**
Vitamin D (IU)***
22.3 ± 10.6
5.5 ± 2.7
32.8 ± 11.3
Values are presented as mean ± SEM.
* Indicates significant difference from pre to post (p < 0.05)
** Indicates significant difference between groups (p < 0.05)
*** Indicates significant interaction (p < 0.05)
No other statistically significant difference noted (p > 0.05)
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Post
1523.0 ± 203.8*
66.4 ± 6.8*
18.5 ± 1.2
206.2 ± 33.3*
53.9 ± 4.0
30.8 ± 4.4*
2.6 ± 0.8*
62.5 ± 7.4*
43.8 ± 6.0*
26.3 ± 2.1*
7.4 ± 1.1*
16.0 ± 2.4
8.7 ± 1.2
0.3 ± 0.2
0.7 ± 0.1
5.2 ± 0.7
68.3 ± 11.5*
109.7 ± 18.2*
7.2 ± 1.3
584.3 ± 165.6*
41.2 ± 5.4*
464.4 ± 56.1*
59.0 ± 15.1

APPENDIX B
EXTENDED LITERATURE REVIEW
Fasting/Dietary Restriction
Investigations involving the consumption of food and the effects on biochemical
parameters of health have been of great interest to researchers over the past several
decades. Food is an essential part of the human existence and therefore, a lack of intake
can lead to malnutrition and death. On the contrary, over-consumption of food, coupled
with a lack of physical activity, results in the excess storage of body fat and weight gain.
The latter statement is seen as one of the driving forces behind many health-related
deaths in developed countries. This has led many investigators to seek the understanding
of how dietary intake impacts human health.
Significant attention has been given to specific dietary regimens and their
potential role in extending lifespan, as well as in preventing disease. Typically, dietary
regimens involve the restriction of calories or the restriction of certain nutrients. Caloric
restriction (CR) and alternate day fasting (ADF) are two dietary regimens that seek to
restrict the overall intake of calories—either on a daily basis or on an intermittent basis.
The restriction of specific components or nutrients from the diet is commonly referred to
as dietary restriction (DR). Several religiously motivated fasts have been investigated
and fall into these categories. The religiously-motivated Daniel Fast, a stringent vegan
diet that has been investigated recently and noted to result in multiple health-related
benefits [1, 2], falls into this category of DR. Other religiously motivated fasts include
Islamic Ramadan, which consists of a fasting period from sunrise to sunset (a form of
ADF), and Greek Orthodox Christianity fasting (GOC), which is also a variant of DR.
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Caloric Restriction
Caloric restriction has been extensively studied in rodents, monkeys, and several
other species in the animalia kingdom. Many of these studies, which are typically carried
out with 20-40% restriction of ad libitum feeding [3], have demonstrated a plethora of
health-related benefits with regards to increasing lifespan [4]. Some of the more
prominent benefits are as follows: improved cardiovascular health, increased insulin
sensitivity and glucose regulation, decreased oxidative damage, favorable changes in
lipid profiles, and reduced production of inflammatory mediators [4, 5]. As a result, CR
has been shown to reduce the onset of age-related diseases such as cardiovascular disease
(CVD), diabetes, and cancer [6, 7].
The favorable effects of CR on cardiovascular health can be attributed to the
following: lowering of resting blood pressure (BP) and heart rate (HR), improved
ventricular function, improved HR and BP response following exercise, increases in HR
variability, and increased flow mediated vasodilation [4]. Moreover, 12 months of 20%
CR in humans has been shown to lower coronary heart disease (CHD) risk factors by
favorably altering blood lipids [8]. Specifically, and along with weight loss, CR induces
its favorable effects by reducing plasma total cholesterol (TC), triglycerides (TAG), lowdensity lipoprotein cholesterol (LDL-C), and total cholesterol/high-density lipoprotein
cholesterol (TC/HDL-C) ratio [8].
There have been many hypotheses regarding the life-extending effects of CR and
the mechanisms involved. One that has gained much support over the last few decades is
the oxidative stress hypothesis [9]. Markers of oxidative stress, such as,
malondialdehyde (MDA), superoxide (O 2•-), and hydrogen peroxide (H2O2) have been
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shown to decline following a CR regimen [9]. A review of investigations in rodents
supports the notion that CR lowers resting levels of oxidative stress, delays the oxidant
damage associated with age, and delays loss of membrane fluidity [10]. A reduction in
energy intake attenuates the production of RONS, sometimes referred to as free radicals
(radicals), that are available to damage proteins, lipids, and deoxyribonucleic acid
(DNA). As lipids and protein make up an integral part of the plasma membrane,
maintaining this barrier is vital for the functionality of cells, organs, and organisms as a
whole. Along with attenuated oxidative stress, CR has also been shown to reduce
inflammation by reducing circulating levels of leukocytes and other inflammatory
markers such as tumor necrosis factor alpha (TNF-α) and C-reactive protein (CRP) [8,
11].
One hypothesis attributes the health-related benefits of CR to an increase in the
metabolic rate. An increased metabolic rate causes a rise in the production of
mitochondrial RONS, which then up-regulates the production of radical-scavenging
enzymes as a defense mechanism [12]. The adaptive response of an increased
antioxidant defense system is speculated as one of the mechanisms responsible for the
anti-aging effect of CR [12]. While the specific mechanisms concerning CR are yet to be
fully determined, the effects of CR on health-related parameters are remarkable as
evidenced above. However, compliance to such a plan can be difficult, in particular
when a higher percentage of calories are removed from the diet (e.g., > 20%). Many
regimens that offer similar health benefits have been proposed in place of CR due to the
strictness of the diet. Some of these diet regimens are developed with the hopes of
promoting long-term compliance and lifestyle changes.
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Alternate-Day Fasting
Due to the rigorous demands of a CR regimen that restricts caloric intake on a
daily bases, other dietary intervention strategies have gained attention in the scientific
community. Alternate-day fasting (ADF) is another form of caloric restriction; however
the regimen differs from CR because restriction occurs every other day. ADF regimens
generally involve alternating days of ad libitum feeding followed by a fasting day on
which food is withheld or reduced. Two forms of ADF exist: A true ADF regimen where
no calories are allowed on the “fast” day [13] and a modified ADF where subjects are
typically restricted to 25% of baseline energy requirements [14].
Studies that involve ADF are mostly carried out in rodents and humans. In a
recent review, ADF investigations on rodents have reproduced some of the same
favorable effects as CR with regards to increasing lifespan, improving CVD risks, as well
as improving variables related to diabetes [15]. Human studies are in their infancy and
have only begun to shed light on the favorable effects of ADF. Regarding cardiovascular
health, ADF in obese individuals has been shown to lower HR and systolic BP, but not
diastolic BP [14]. However, changes in BP are not seen in healthy normal weight
individuals [16]. Like CR, ADF favorably alters CVD risk factors by improving ones
blood lipid profile [17], decreasing markers of oxidative stress and inflammation [18],
and improving glucoregulatory function [19].
Regarding the effects of ADF on glucoregulatory health, fasting levels of plasma
glucose and insulin are not affected; however, it does appear that insulin sensitivity
increases in as little as two weeks, as measured by the euglycemic-hyperinsulinemic
clamp technique [19]. Insulin sensitivity following ADF has been shown to be gender
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specific. Heilbronn et al (2005) noted a decrease in glucose clearance following a test
meal in healthy females after 3 weeks of ADF. This decrease was not observed in men,
but more importantly, there insulin concentrations significantly decreased following the
meal indicating improved insulin sensitivity [13].
An ADF dietary regimen has been shown to improve blood lipids by decreasing
plasma TC, LDL-C, TAG, while having no effect on HDL-C [20]. Others have found
gender specific changes in TAG and HDL-C following an ADF regimen (i.e. only
women had an increase in HDL-C and only men a decrease in TAG) [16]. Moreover, 8
weeks of an ADF regimen has been shown to reduce LDL-C while also reducing the
proportion of small dense LDL particles and increasing the proportion of large LDL
particles [17].
Reduced markers of oxidative stress, as measured by protein carbonyls,
nitrotyrosine, and 8-isoprostanes, have been observed in overweight adults with moderate
asthma following 8-weeks of an ADF regimen. This investigation also noted significant
reductions in TNF-α and ceramides indicating a reduced inflammatory state. In addition,
similar reductions in CRP, TC, LDL-C, and TAG were noted between both groups
undergoing a CR or ADF diet [18]. While ADF and CR have been demonstrated to
increase lifespan [4] and help prevent the age-induced onset of disease [15], protein
restriction has produced similar results. This has led some to conclude that protein
restriction could be responsible for some of the health-related benefits of the
aforementioned diets [21].
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Dietary Restriction
Dietary restriction (DR) is a dietary regimen that restricts certain components of
the diet, usually macronutrients, without necessarily restricting overall caloric intake.
Protein restriction (PR) is a form of DR and has shown to induce favorable health-related
benefits in mammals [22]. Investigations on PR usually reduce protein intake by 4085%, some with varying degrees of caloric restriction (reviewed in [21]), and others in
which protein is replaced with carbohydrates/fats (reviewed in [22]). According to a
review by Pamplona et al (2006), increases in lifespan have been found in almost every
study with regards to mammals and PR. However, the effects of PR on life extension
was approximately half (20%) of what is typically found in CR (40%), indicating that PR
could be responsible for 50% of the life-prolonging effects of CR [21].
There is an increasing body of evidence that indicates that the amino acid most
responsible for the life-extending effects of PR is methionine—known as methionine
restriction (MR) [23]. In particular, MR (by 40-80%) in rats has been shown to inversely
correlate with maximum lifespan potential [22]. Compared to control groups, MR in rats
has also been shown to decrease biomarkers of oxidative stress [24], decrease
mitochondrial RONS [24], and improve glucoregulatory function by decreasing serum
glucose, insulin, and IGF-1 [25]. Some of these benefits are not observed with the
restriction of lipid and or carbohydrates [26], and therefore, the central focus remains on
elucidating the life-extending mechanisms of PR.
There remains much to be understood with regards to MR in humans. Vegetarian
diets tend to be low in methionine content and studies have consistently demonstrated
improvements in blood lipids and decreased age-associated oxidative stress (reviewed in
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[27]). With regards to blood lipids, vegetarian diets are associated with reductions in TC,
LDL-C, very low-density lipoprotein cholesterol (VLDL-C), TAG, and little to no
decreases in HDL-C [27]. Vegetarian diets have little effect on oxidative stress in
women (age: 20-40 years) when compared to age-matched non-vegetarians [28, 29].
However, there does appear to be some efficacy in lowering age-related oxidative stress
levels in older individuals (age 60-70), as measured by oxidized purines, oxidized
pyrimidines, and conjugated dienes of fatty acids [28]. A recent study using a stringent
variant of a vegan diet (Daniel Fast) has noted a reduction in oxidative stress biomarkers
[1].
In addition to the above changes with MR, data appear to favor reduced
circulating inflammatory mediators; however, there are conflicting findings.
Investigations have noted significantly lower CRP in vegetarians when compared to agematched non-vegetarians [30, 31]. However, others have found no difference in plasma
CRP, between vegetarians and omnivores (age: ~37) [29]. One investigation also
indicated reduced concentrations of serum insulin-like growth factor-1 (IGF-1) in
moderately protein restricted (0.95g/kg of body weight per day) [32]. Interestingly, longterm (1 and 6 years) CR in humans does not reduce serum IGF-1 [32], and this is contrary
to the ~40% reduction shown in rodent studies [33]. More importantly, decreased IGF-1
concentrations have been associated with increased lifespans in rodents [34]. Many of
the favorable outcomes associated with a vegetarian diet are analogous to the effects of a
Daniel Fast [1, 2], and it is possible that MR may account for a large portion of these
observed benefits.
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Religious Fasting
Ramadan
The Islamic Ramadan fasting period is similar to a modern day ADF regimen,
consisting of alternate feeding and fasting periods over the course of the 24 hour day.
During the holy month of Ramadan, people of the Muslim faith refrain from eating or
drinking from sunrise to sunset, and then feed ad libitum from sunset to sunrise for 28-30
days [35]. Very little agreement exists on various outcome measures of health following
Ramadan fasting (reviewed in [36]). Only one study has investigated the effects of
Ramadan fasting on oxidative stress, and this study found reduced levels of MDA in
erythrocytes with no changes in serum MDA or plasma protein-bound carbonyls in
healthy men and women [37]. During Ramadan fasting in young healthy men and
women, IL- 6 and CRP have been reported to significantly decrease when compared to
basal levels [38]. Additionally, significant reductions in fasting blood glucose, the
homeostatic model assessment for insulin resistance, and TNF-α have been noted in
obese and healthy males [39].
Heterogeneous findings have been reported on for the following: systolic and
diastolic blood pressure, TAG levels, glucose levels, HDL-C, LDL-C, and LDL-C/HDLC ratio. It is evident that these findings were potentially mixed due to a number of
confounding variables. Some of these variables include different population types,
different amounts of fasting time, and differences between food choices and eating habits
of different cultures (reviewed in [36]). It is recommended that future research consider
these confounding variables when designing a study in order to better understand the
effects of Ramadan fasting on these particular health-related markers.
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Greek Orthodox Christianity
Three periods during the year comprise the GOC fasting regimens: the Nativity
fasting period, Easter Lent, and the Assumption. Together, these periods restrict dietary
consumption for 180-200 days of the year. During the fasting periods, the diet can be
considered a form of DR and a variant of vegetarianism, consisting largely of bread,
fruits, nuts, legumes, vegetables, and seafood [40]. While a diet with such a profile
appears to be healthy, the effects of GOC fasting periods on some health biomarkers are
conflicting. Decreases in TC and LDL-C have been noted following periods of fasting
[40, 41]. However, findings are conflicting with regards to TAG, HDL-C, TC/HDL-C
ratio, and blood pressure (reviewed in [36]).
The three GOC fasting periods contain different dietary instruction with regards
to meat, fish, and olive oil; which could explain for some of the variance seen between
studies. The effect of GOC fasting periods on oxidative stress and inflammatory markers
has not been addressed. While more work needs to be done in addressing each fasting
period individually, there does appear to be parallelism between GOC fasting periods and
vegetarianism. The Biblically-based Daniel Fast shares similarities with GOC in some
way, and will be elaborated on at the conclusion of this literature review.
Blood Lipids
The major lipids in the blood are cholesterol, TAG, and phospholipids. Due to
the insoluble nature of these lipids they are packaged into complexes of lipid and protein
(lipoproteins) for transport in the blood. These particles have important biological roles,
including but not limited to, energy storage, cell membrane integrity, and cell signaling
(reviewed in [42]). Many countries are experiencing the adverse effects from these
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particles in the form of developed CVD, as CVD is the main causes of death in the
United States and other industrial nations [43]. While epidemiologic studies define lipid
disorders as independent risk factors for CVD [44], intervention studies have shown that
treating these abnormalities decrease the risk for cardiovascular events [45].
Lipid panels are blood measurements that attempt to assess the likelihood of
developing coronary heart disease (CHD). Levels of HDL-C, LDL-C, VLDL-C, TC, and
TAG are analyzed to give a measurement of the amount of each particle that is present in
the blood. This section of the review will discuss each variable in the lipid panel, as well
as the TC/HDL-C ratio and the LDL-C/HDL-C ratio. In addition, this section will be
concluded with a discussion regarding the methods available to improve one’s lipid
profile, such as pharmacological, nutraceutiacal, exercise, and dietary interventions.
Low-Density Lipoproteins
Low-density lipoprotein cholesterol functions to carry serum cholesterol (~6070% of total serum cholesterol) from the liver to peripheral tissues. When levels of LDLC are in excess, the smaller particles are more prone to penetrate into the arterial wall,
which then exposes them to oxidation via radicals in the blood (reviewed in [46]).
Atherosclerosis is characterized by the hardening of the vessel due to buildup of fatty
material. An early step in the progression of atherosclerosis is the inflammatory immune
response due to the oxidation of LDL-C in the arterial wall (reviewed in [46]).
The National Institute of Health (NIH) recommends that serum LDL-C be less
than 100 mg/dL for optimal cardiovascular health. The mean level of serum LDL-C
among U.S. adults is 120 mg/dL, and 70.9% of this population has serum LDL-C levels
above the recommended 100 mg/dL [47]. Low-density lipoprotein cholesterol has been
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identified by the Adult Treatment Panel (ATP) III of the National Cholesterol Education
Program (NCEP) as the major atherogenic lipoprotein and the primary target for
cholesterol-lowering therapy [48]. High LDL-C is a modifiable risk factor in the
development of heart disease, and a reduction of this lipoprotein would be favorable in
reversing the risk of cardiovascular related events (e.g., myocardial infarctions and
strokes) [47].
Lower LDL-C levels should be of greatest importance to individuals who are
seeking to improve cardiovascular health. With regards to a target LDL-C level, less than
100 mg/dL would be optimal for cardiovascular health, but individuals will differ based
on the number of risk factors for CHD [48]. Due to the high risk associated with elevated
LDL-C and cardiovascular related events [49], there have been many investigations
focused on lowering serum LDL-C levels, some of which report greater benefit than
others [50]. While pharmaceutical therapy takes a more aggressive approach in
achieving the reduction of LDL-C, diet regimens have also shown to produce favorable
outcomes with less adverse side effects [51].
High-Density Lipoproteins
High-density lipoprotein cholesterol (HDL-C) makes up 20-30% of the total
serum cholesterol and a high level is strongly and inversely associated with risk for CHD.
Serum HDL-C levels lower than 40 mg/dL is classified as low in men and lower than 50
mg/dL is low in women [52]. There has been some evidence suggesting that HDL-C can
protect against atherosclerosis mainly due to its role as a reverse cholesterol transport
lipoprotein [53]. During the process of reverse cholesterol transport, excess cholesterol
from the arterial wall’s foam cells are returned to the liver for excretion (reviewed in

37

[54]). In addition, HDL-C has shown to inhibit thrombosis, prevent oxidation of LDLs
with its antioxidative activity, and protect the endothelium against inflammation by
increasing nitric oxide (NO) bioavailability (reviewed in [55]).
Low HDL-C concentration has been identified as an independent risk factor for
the development of CHD [48]. Low HDL-C levels also correlates with the presence of
other atherogenic factors such as elevated serum TAG, small remnant LDL particles, as
well as signs of insulin resistance [48]. It is estimated that greater than 40% of coronary
events occur in individuals with less than 40 mg/dL HDL-C [55]. Considering this
finding, a level greater than 40 mg/dL HDL-C would be favorable when considering
optimal cardiovascular health.
High-density lipoprotein cholesterol possesses enzymes that can prevent the
formation of inflammatory mediators. In addition, HDL-C inhibits the expression of
adhesion molecules and migration of monocytes into the subendothelial space [56]. Due
to the inflammatory role in the development of atherosclerosis [46], and the antiinflammatory properties of HDL-C [57], raising HDL-C has developed as a therapeutic
target to complement LDL-C lowering therapies [48]. The development of drugs aimed
at increasing HDL-C is a fast growing area of research [50]. It has still yet to be seen
whether or not this approach translates into the reduction of cardiovascular related events,
however, there is an increasing amount of evidence that supports this [55, 56, 58].
Triglycerides, Very Low-Density Lipoproteins, and Non-High-Density Lipoproteins
Triglycerides are transported in the blood as chylomicrons or VLDL-C. Very
low-density lipoprotein cholesterol makes up ~10-15% of the total serum cholesterol and
is a TAG-rich lipoprotein that also contains cholesterol esters in the lipid core. The
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formation of VLDL-C is ultimately dependent on the availability of cholesterol and TAG
as a substrate [59]. In the peripheral tissue, lipoprotein lipase acts on the TAG rich
VLDL-C, extracting free fatty acids (FFA) for the uptake and storage of TAG. Due to its
large size, VLDL-C particles rarely enter into the arterial wall. However, hepatic lipase
and lipoprotein lipase hydrolyzes TAG in the lipid core rendering a VLDL remnant that
is predominantly cholesterol esters with similar atherogenic characteristics as LDL-C
(reviewed in [51]).
Resting TAG levels greater than 150 mg/dL has been recognized as less than
optimal by the ATP III of the NCEP [48]. This value is 50 mg/dL lower than what was
recommended in the previous panel indicating an increasing awareness of the health risk
associated with elevated TAG. Elevated TAG (greater than 200 mg/dL) is associated
with an increase in atherogenic lipoproteins and increases the risk of CVD beyond that of
which LDL-C predicts alone [48]. Therefore, non-HDL-C is a secondary target of
therapy in individuals with TAG greater than 200 mg/dL [44]. It has been postulated that
hypertriglyceridemia promotes cholesteryl ester exchange via the cholesteryl ester
transfer protein (CETP). High serum TAG increase the transfer rate of cholesteryl ester
from HDL-C to VLDL-C, resulting in low serum HDL-C and the formation of small
dense LDL-C—which increases ones vulnerability to plaque formation (reviewed in
[59]).
A normal level of VLDL-C is less than or equal to 30 mg/dL and therefore a
target goal for non-HDL-C is 30 mg/dL higher than LDL-C. The National institute of
Health identifies elevated VLDL-C remnants as a risk factor for the development of
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atherosclerosis due to specifically cited evidence that shows an increased risk of CHD
with increasing levels of TAG-rich lipoproteins [48].
Non-HDL-C, the sum of VLDL+LDL-C, is a better predictor for CVD risk
assessment when TAG are elevated above 200 mg/dL. It appears as though LDL-C alone
does not adequately assess the risk of CVD when TAG are elevated due to the strong
correlation between VLDL-C and atherogenic remnant lipoproteins [44]. Some data
actually favor the use of non-HDL-C over LDL-C in clinical evaluation of risk [48].
Apolipoprotein B (Apo B), which is the main lipoprotein in LDL-C, is associated with all
forms of atherogenic lipoproteins and therefore it is also a strong predictor for CHD [48].
When TAG are elevated, non-HDL-C (including VLDL-C) can serve as a secondary
target of therapy [48].
Total Cholesterol and Cholesterol Ratios
Total cholesterol is the amount of all lipoproteins present in the blood. Currently
it is recommended that TC be less than 200 mg/dL [48]. Statistics indicate that
individuals with higher cholesterol levels have more cardiovascular related diseases than
those with lower levels [48, 60]. Moreover, clinical trials have indicated that a 1%
reduction in TC reduces CHD by 2% [49]. There is an apparent relationship between TC
and LDL-C due to the simple fact that the majority of lipoprotein particles in the blood
exist as LDL-C [55]. Therefore, it would be beneficial for individuals to reduce TC
while maintaining HDL-C levels when considering health from a cardio-protective
standpoint.
The TC/HDL-C ratio has been characterized an emerging lipid risk factor. It can
be used as a better predictive measure for classifying individuals at risk for CVD when
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compared to TC, LDL-C, and HDL-C alone. However, ATP III of the NCEP does not
indicate the TC/HDL-C ratio as a primary or secondary target of therapy; rather, it is used
as a predictor for lipid risk assessment. This risk can be attributed to the nature of the
lipoprotein particles associated with each number in the ratio. In short, the ratio reflects
two powerful components of risk by considering the atherogenic properties related to TC
and the anti-atherogenic properties of HDL-C [48, 49]. Similarly, the LDL/HDL-C ratio
is equally effective in predicting cardiovascular risk [49]. This can be credited to the
close relationship between LDL-C and TC. As stated earlier, LDL-C and TC values are
closely related due to the fact that LDL-C makes up the majority of TC [55]. However,
when the TAG concentrations exceed 300 mg/dL, the LDL/HDL-C ratio may
underestimate the magnitude of lipoprotein abnormalities [49].
Improving Blood Lipids
Pharmaceuticals
Pharmaceutical therapy is available for individuals with elevated blood lipid
levels who are at a high risk for developing atherosclerotic disease. Drugs such as statins
(HMG-CoA reductase inhibitors) are first line therapy treatments and have been shown to
reduce LDL-C in the range of 18-55% and TAG 7-30% by inhibiting synthesis of
cholesterol (reviewed in [51]). With marginal increases of HDL-C, ranging from 7-30%,
the lowering of LDL-C from statins appears to be the major factor in the reduction of
cardiovascular mortality [48, 50, 61].
Cholesterol absorption inhibitors are a class of drugs that interfere with dietary
cholesterol uptake into the intestinal wall to lower blood lipids [62]. According to a
recent meta-analysis, Ezetimibe in particular, when paired with statin therapy, has been
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shown to more aggressively reduce LDL-C to help patients reach their cholesterol goal
[62]. Like cholesterol absorption inhibitors, bile acid sequestrants can also be used in
addition to statin therapy to help reduce LDL-C an additional 12-16% [48]. Nicotinic
acid (Niacin) on the other hand is the most effective pharmacologic method for
increasing HDL-C (15-35% with 1.5-3.0g/day) while also showing a 5-25% reduction of
LDL-C and 20-50% reduction in TAG (reviewed in [50, 51, 61]). Fibric acids (Fibrates)
are another widely used lipid-modifying pharmaceutical that demonstrates less significant
improvements in both HDL-C (15-35% increase) and LDL-C (5-20% reduction) but are
predominantly used to lower TAG (20-50%) via the up-regulation of lipoprotein lipase
[51, 61].
A healthy lifestyle that involves adequate exercise and optimal nutrient intake is
an alternative to lowering blood lipids without the use of pharmacological interventions.
These types of changes are regarded as therapeutic lifestyle changes by the NCEP [48].
Exercise and diet can allow for better maintenance of weight and body composition with
a reduction in total body fat and visceral body fat. In addition, dietary supplements have
become another alternative that many people have turned to for blood lipid management.
Dietary Supplements
One non-pharmacological intervention that has received much interest is the use
of nutraceuticals. Nutraceuticals are foods that have shown to provide health benefits and
can be used as supplementation for the treatment of disease [63]. The following has been
demonstrated to improve one’s lipid profile with regard to LDL-C: Vitamin E (8-42%
reduction), guggulipid (5-12% reduction), ginseng (10% reduction), probiotics (5-8%
reduction), sesame oil (10%), red yeast rice (22-32% reduction), and pantethine (20-27%)
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[58]. The following nutraceuticals have shown efficacy in elevating HDL-C: pantethine
(8.4% increase), red yeast rice (0-20% increase), policosanol [58]. While supplements
can assist in the modification of blood lipids, macronutrient intake affects them as well.
Exercise
Regular aerobic exercise has shown to elicit improvements in HDL-C, TAG, and
LDL-C. Specifically, aerobic exercise at moderate to high intensity for greater than 12
weeks has been shown to increase HDL-C 4.6%, and decrease TAG and LDL-C by 3 and
5% respectively (reviewed in [64]). However, these changes are dependent on baseline
lipid measures, exercise intensity, and duration. There exist confounding findings in
many of the studies reviewed, and this is attributed to the different methodologies and
variations in subject types. A meta-analysis regarding progressive resistance training for
greater than four weeks indicates significant reductions in LDL-C, TAG, non-HDL-C,
TC, and TC/HDL-C ratio by 6.1, 8.1, 8.7, 5.5, and 0.5 mg/dL respectively [65]. Exercise
has also been shown reduce the onset of type 2 diabetes mellitus (T2DM) by 56%; more
effective than pharmaceuticals such as metformin and troglitazone [58]
Nutrients
Due to the increase in cardiovascular related deaths around the world, an
abundance of research has focused on the effects of nutrient intake on blood lipid
parameters. Specifically, investigators have sought to determine the effects of adding or
removing components from the diet, both macro- and micro-nutrients. There is an
increasing amount of evidence that indicates improvements in blood lipid parameters
when substituting saturated fatty acids (SFA) for polyunsaturated (PUFA) and
monounsaturated fatty acids (MUFA) [66, 67]. When compared to a corresponding SFA
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diet equal in fat quantity (30-33%), replacing ~9% of SFA with either PUFA or MUFA,
leads to reductions in TC (19 and 12%), LDL-C (22 and 15%), TC/HDL-C ratio (6 and
8%), TAG (15% for both), and HDL-C (14 and 4%) after two and a half weeks of dietary
intervention [66]. Furthermore, studies have shown a 42% reduction in CHD risk when
replacing 5% of energy from SFA with MUFA and PUFA [68]. Additionally, studies
have demonstrated favorable results, with regard to elevating HDL-C, when
incorporating n-3-polyunsataurated fatty acids and low-GI carbohydrates [58, 61].
Conversely, some believe n-3-PUFA to mainly influence the lowering of VLDL-C and
therefore TAG as well, while having minimal influence on LDL-C and HDL-C [51]. On
the contrary, evidence indicates that trans-fatty acid rich diets increase LDL-C and
decrease HDL-C, significantly increasing the risk factor for cardiovascular events [68].
The glycemic index indicates the effects of a food on blood glucose
concentrations. The type of carbohydrate, with regards to their glycemic index, has been
suggested to be a relevant determinant of CHD risk in some studies; with an increased
risk from high glycemic refined carbohydrates [67]. In addition, a phenomenon known
as carbohydrate-induced hypertriglyceridemia has given rise to research regarding the
efficacy of lowering carbohydrate consumption. A carbohydrate-rich diet has shown to
increase TAG as well as VLDL-C, more so in overweight individuals (BMI > 28 kg/m2)
than in normal weight individuals (BMI < 28 kg/m2) [69]. Similarly, a recent review
favors the replacement of SFA with PUFA and MUFA over the replacement of SFA with
higher carbohydrate intakes; with lower LDL-C and HDL-C from the former and
increased TAG, smaller LDL-C particles, and reduced HDL-C from the latter [67].
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Similarly, others cite evidence for a low-carbohydrate dietary approach that reduces TAG
and LDL particle size while increasing HDL-C [70].
With regards to protein consumption, a protein rich diet (30% protein, 41%
carbohydrate, and 29% fat) for 10-weeks has been shown to significantly reduce TC,
LDL-C, and TAG , while having no effect on HDL-C [71]. A 6-week protein rich diet
(25% daily kcal requirements, ~50% plant sources) in pre-hypertensive adults found
similar results in all of the aforementioned variables, however, a significant reduction in
HDL-C (1.3 mg/dL) was observed [72]. A recent meta-analysis indicates that a diet rich
in soy protein containing isoflavones results in the decreases of TC (3.77%), LDL-C
(5.25%), TAG (7.27%), and an increase in HDL-C (3.03%). Data from this metaanalysis also indicates that reductions in TC, LDL-C, and TAG occurs in short term
intervention trials, whereas increases in HDL-C were only observed in interventions
lasting greater than 12 weeks [73].
Aside from macronutrients, other components have also shown to influence blood
lipids. It is known that increases in dietary cholesterol and fat results in increases in
plasma cholesterol levels [74]. Recent reviews indicate that the addition of the following
foods to the diet has been associated with declines in LDL-C: vegetables, grains, plant
sterols, viscous fiber, soy protein, and nuts. Specifically, dietary fiber intake, when
included with a diet low in SFA and cholesterol, lowers LDL-C (5-10%) [58, 61].
Studies involving healthy, as well as hypercholesterolemic subjects have shown that the
intake of nuts lowers TC, LDL-C, and the LDL-C/HDL-C ratio. Moreover,
epidemiological studies found an 8.3% reduction in risk of death from CHD for each
weekly serving of nuts (reviewed in [68]). While changes regarding blood lipids remain
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an area of focus for improving the health of individuals in many developed countries,
oxidative stress is another area that has garnered a great deal of attention.
Oxidative Stress
Free radicals are atoms, molecules, or ions that have unpaired electrons [75]. The
formation of electrons pairs is more energetically favorable and therefore, molecules with
unpaired electrons are more reactive. The reactivity of such molecules, specifically those
derived from oxygen and nitrogen, has been shown to play an important role in biological
processes. Reactive oxygen and nitrogen species (RONS) are products of normal cellular
metabolism. These reactive products facilitate redox homeostasis through cellular
signaling molecules that are necessary for specific initiation and/or signal transduction
pathways [76]. The redox state of a cell is very tightly regulated and depends on the rate
of RONS production, as well as their removal by an intricate antioxidant defense system
that includes, but is not limited to, superoxide dismutase (SOD), glutathione (GSH),
catalase, alpha lipoic acid, and coenzyme Q10 (CoQ10) [76]. In short, RONS participate
in various redox-regulatory mechanisms, but when RONS production exceeds antioxidant
defense systems, oxidative damage to molecules such as DNA, proteins, lipids and
carbohydrates can occur. This oxidative insult is termed oxidative stress [77].
Causes of Oxidative Stress
Oxidative damage affects cellular lipids, DNA, and proteins in tissue and occurs
at certain levels in all animals. Many investigations suggest that steady-state oxidative
damage to macromolecules occurs to a greater extent with increasing age in organs like
the liver, heart, and brain (reviewed in [21]). Enzymes such as, nicotinamide adenine
dinucleotide phosphate (NAD(P)H) oxidase, NO synthases, cytochrome P450 oxidase,
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xanthine oxidase, and cyclooxygenase have been shown to be a source of radical
production, as well as various mediators, cytokines, and growth factors [78]. In addition,
RONS production can be acutely increased due to stressors in the form of environmental
pollutants (e.g., cigarette smoke, ozone, nitrogen dioxide) [77], acute physical exercise
[79], and the metabolism of food [80]. Feeding-induced oxidative stress, which is
referred to as “postprandial oxidative stress”, has been shown to occur following lipid
[81, 82], protein [82], and carbohydrate [83] consumption.
Postprandial oxidative stress
Following feeding, glucose and FFA metabolism results in the formation of O 2•radicals via leakage of electrons from the mitochondrial electron transport chain (ETC).
During the metabolism of a high-calorie meal, rich in carbohydrates and/or lipids, the
processing of substrates through the ETC results in a highly reduced inner mitochondrial
membrane [84]. The result is the excessive supply of electrons to complex II, causing a
backing up of electrons at complex-I in the ETC. Electron leakage and the ensuing
formation of O2•- following feeding is believed to predominantly occur at complex-I;
however, evidence also indicates electron leakage and O 2•- generation to a lesser degree at
complex-III [85]. Superoxide formation leads to a shift in the redox environment through
the formation of H2O2. This disruption in homeostasis and direct interaction with the O 2•radical leads to the activation of several pro-inflammatory transcription factors [86]. This
aforementioned pathway has been proposed as a mechanism responsible for acute
decreases in insulin sensitivity, leading to a hyperglycemic/hypertriglyceridemic state.
During conditions of hyperglycemia and hypertriglyceridemia, following the
consumption of a meal, the vasculature appears to be vulnerable to oxidative damage.
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This is in part due to the endothelium’s lack of cellular machinery that restricts the entry
of substrate within the vasculature [87]. During high carbohydrate feedings, glucose
enters the endothelium via a non-insulin dependent mechanism, resulting in endothelial
intracellular hyperglycemia. It has been hypothesized that the lack of specific
mechanisms in endothelial cells whereby glycemic control can be obtained, results in
endothelial dysfunction through the generation of RONS and the subsequent downstream
effects (reviewed in [88]). Superoxide generation within the vasculature triggers the
migration of phagocytic cells to the endothelial surface, which then promote secondary
RONS production and activation of inflammatory transcription factors (reviewed in [89,
90]). To summarize, postprandial RONS production can lead to the activation of
transcriptional factors that favor the production of pro-inflammatory cytokines. In
addition, inflammatory cytokines induced from stress leads to the formation of RONS.
This cyclical process, which is reviewed in [78], can play a role in the pathogenesis of
disease due to the deleterious effects on the endothelial cells.
Measuring Biomarkers of Oxidative Stress
Biomarkers are molecules that can be measured and evaluated as an indicator of
normal biological processes. One way to measure the degree of oxidative stress in the
body is through the analysis of biomarkers in biological tissue and urine [91]. Some of
the RONS capable of oxidizing biomolecules include: NO, O 2•-, peroxyl radicals (ROO•),
peroxynitrite anion (ONOO --), H2O2, and hydroxyl radicals (OH•). The concentration of
RONS production can be directly measured by electron spin resonance (ESR)
spectroscopy. Spin traps, which are molecules that react with primary radical species to
give longer lived secondary radical species can be used to help measure RONS
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production [92]. Electron spin resonance (ESR) spectroscopy is currently the only direct
measure of oxidative stress analysis in vivo. This method measures the magnetic
properties of unpaired electrons and their molecular environment. This method however,
is less than ideal and is not commonly used in research. Indirect measures of oxidative
stress include the end products of protein oxidation/nitration, DNA oxidation/nitration,
and lipid oxidation. While RONS are typically short-lived and relatively unstable, the
measurement of more stable molecular end products resulting from oxidative damage
allows for an indirect measurement of oxidative stress. Aside from measuring RONS, the
total antioxidant capacity (TAC) can be used to represent oxidative stress changes in vivo.
Protein oxidation/nitration
Damage to proteins can occur directly via RONS production, or indirectly via
secondary products. Individual oxidized amino acids can be measured to detect protein
oxidation/nitration; however, two common biomarkers used are protein-bound carbonyls
and nitrotyrosine [93]. Protein carbonyls are generated by direct oxidation of amino acid
residues or via secondary reactions with primary oxidation products of lipids and sugars.
Recently reviewed in [94], the cleavage of peptide bonds, the oxidation of glutamyl
residues, and metal-catalyzed oxidation of protein side-chains render highly reactive
carbonyl derivatives. Some of the common methods for the detection of carbonylated
proteins include: spectrophotometric 2,4-dinitrophenylhydrazine (DNPH) assay,
spectrophotometric DNPH assay coupled to protein fractionation by high-performance
liquid chromatography (HPLC), and one- or two-dimensional electrophoresis and
Western blot immunoassay (reviewed in [93]).

49

Nitration of the amino acid tyrosine results in the formation of 3-nitrotyrosine,
which is another viable biomarker to measure protein oxidation/nitration [95]. A variety
of methods are available to quantify the presence of 3-nitrotyrosine in blood plasma:
enzyme-linked immunosorbent assay (ELISA), HPLC with electrochemical detection,
mass spectrometry-based assays, gas chromatograph-tandem mass spectrometry [93].
While it has been reported that only ONOO -- will nitrate tyrosine residues under
physiological conditions, others have shown multiple pathways for the formation of 3nitrotyrosine [92]. In addition, recent reviews have raised concern over the quantification
of 3-nitrotyrosine, due to varied plasma concentrations of free and protein-bound 3nitrotyrosine in healthy subjects [93]. The downstream effects of protein structure
modification include inhibition of enzymatic and binding activities, increased
susceptibility to aggregation and proteolysis, increased or decreased uptake by cells, and
altered immunogenicity. In addition, oxidative damage to proteins can contribute to
secondary damage to DNA repair enzymes and DNA polymerases (reviewed in [91]).
DNA oxidation/nitration
The highly reactive OH• is one of the main contributors to DNA damage,
(reviewed in [96]). Oxidized DNA bases and strand breaks can be measured to quantify
oxidative damage to DNA. Oxidation products of the DNA base guanine, specifically 8hydroxy-2’-deoxyguanosine (8OHdg), is the most commonly used biomarker due to its
mutagenic characteristics reflected in its coding properties (reviewed in [97]. The
measurement of oxidative damage to DNA can be quantified by HPLC with
electrochemical detection, gas chromatograph-mass spectrometry, liquid chromatograph
mass spectrometry, and antibody based techniques (reviewed in [91, 98]. Biological
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samples are typically obtained from blood serum, lymphocytes, myocardium, liver and
urine. However, none of the analytical methods identify where the oxidative DNA
damage is located [93]. Measurement of 8OHdg in urine is advantageous because it can
be used to assess whole-body oxidative DNA damage, however, it has been speculated
that the concentration of a single product may not truly reflect rates of oxidative damage
to DNA [98].
Lipid Oxidation
Lipid peroxidation is characterized by the oxidation of lipids in the plasma
membrane. Lipid peroxidation can be initiated by the removal of a hydrogen atom from a
carbon side chain. This leads to the formation of a carbon centered lipid radical that
mostly reacts with O2, forming a ROO•. Peroxyl radicals can abstract hydrogen from
adjacent fatty acid side chains, particularly unsaturated fatty acids with weak
carbon/hydrogen bonding, thereby initiating the chain reaction of lipid peroxidation [99].
Lipid peroxidation damages the degree of fluidity through the plasma membrane which
can play a role in the impairment of normal cellular functions. Many methods can be
used to detect and measure lipid peroxidation, but the use of blood plasma/serum, breath
condensates, and whole organs are typical (reviewed in [100]). Some of the more
prominent biomarkers of lipid peroxidation include MDA and F2-IsoPs. However, other
relatively stable end products can be measured such as lipid hydroperoxides, α,βunsaturated reactive aldehydes, conjugated dienes, oxidized low-density lipoprotein, 4hydroxy-2-nonenal, and 2 propenal (acrolein) (reviewed in [91]).
Malondialdehyde is formed when RONS react with unsaturated lipids [99]. In
addition, MDA reacts to form protein and DNA adducts that behave mutagenically
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(reviewed in [101]). The most common method used for measuring MDA is the
thiobarbituric acid (TBA) test. The TBA test is frequently carried out under acidic
conditions at ~100°C, resulting in a condensation reaction that gives rise to a high
absorbtivity adduct (TBA2-MDA) that can be spectophotometrically analyzed at an
absorbance/fluorescence of 532/553 nm (reviewed in [100, 101]). The measurement,
which is usually reported as “TBA reacting substances” (TBARS), indicates the degree of
lipid peroxidation, however this method has been faulted for its lack of specificity and the
ability of TBA to react with other compounds other than MDA [102].
F2-isoprostanes (F2-IsoPs) are a group of prostaglandin-like compounds that are
generated by radical induced peroxidation of arachidonic acid, an omega-6 fatty acid in
the phospholipids of cell membranes [103]. The detection of F2-IsoPs can be quantified
in all human fluids and tissues, but human plasma and urine are the most common
methods for quantifying F2-IsoPs. Recent reviews indicate that the quantification of F2IsoPs in urine and plasma give highly accurate indices of radical mediated lipid
peroxidation in vivo [91, 104]. Several methods for analyzing F2-IsoPs exist (reviewed in
[104]), but mass spectrometric assays are advantageous because they are more
sensitive/specific. In the field, mass spectrometry is considered the gold standard for F2IsoPs quantification; however, this method is labor-intensive and requires significant
expenditures on equipment.
Total Antioxidant Capacity
Plasma total antioxidant capacity (TAC) reflects the synergistic activity of
antioxidants and can be used to help evaluate the effects of different treatments (e.g.,
diets) on plasma redox status. This characteristic of the test allows for a “bigger picture”
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of in vivo oxidative stress, when compared to measuring specific antioxidants/RONS.
Blood TAC measurements, preferably plasma, can be obtained by quantifying the amount
of RONS scavenged from a known quantity of a given RONS (reviewed in [105]). Data
suggests that dietary TAC may help estimate the risk in developing metabolic syndrome
features [106]. Other data demonstrate that TAC is a potential marker of diet quality in
healthy subjects [107]. Antioxidant capacity can be measured using at least two different
types of assays: hydrogen atom transfer reaction based assays and single electron transfer
reaction based assays. The electron transfer reaction based assays are more commonly
used, this group includes assays such as the Trolox Equivalent Antioxidant Capacity
Assay (TEAC), the ferric ion reducing antioxidant power assay (FRAP), the N,Ndimethyl-p-phenylenediamine assay, and the Cu(II) reduction capacity assay (reviewed in
[108]. Two common hydrogen atom transfer reaction based assays are the oxygenradical absorbing capacity (ORAC) and the total radical-trapping antioxidant parameter
(TRAP). These two methods measure the ability of an antioxidant to quench radicals by
hydrogen donation [109]. Both assays use peroxyl radicals as the oxidant and measures
the radical chain breaking capacity of the sample [110]. While TAC appears to be a
useful concept, these methods have been criticized for yielding different results based on
the conditions in which the assays are run [108], and therefore caution needs to be used
when analyzing the results.
Implications for Health and Disease
As mentioned previously, the production of RONS is an essential biological
process that aids in cellular redox homeostasis and signal transduction pathways [76]. It
is conceivable that high levels of RONS production is detrimental and is one of the
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underlying mechanisms in the pathophysiology of many illnesses/diseases [76, 78, 88,
90]. As such, the role of oxidative stress on the progression of disease will be discussed
in further detail.
Insulin Resistance
Oxidative stress can damage surrounding biomolecules, inhibit the systematic
functions of lipids, proteins, and DNA, and induce low grade systemic inflammation.
Evidence has demonstrated proportional increases in oxidative stress and feeding-induced
hyperglycemia/hypertriglyceridemia. During times of high calorie/fat feeding, these
oxidative insults promote a decrease in insulin sensitivity in adipose and muscle cells, as
shown in [111]. This state of insulin resistance is derived from the formation of O 2•following feeding, possibly as a defense mechanism of the cell to prevent further damage
from the metabolism of substrate. One proposed mechanism for this insulin resistant
response is the translocation of glucose transporter type 4 (GLUT 4) from the plasma
membrane [87]. Following postprandial oxidative stress, mitochondrial production of
O2•- is reduced due to the inhibition of intracellular FFA oxidation [112]. Studies have
shown that prolonged low-levels of oxidative stress impair insulin mediated GLUT 4
translocation, ultimately leading to impaired glucose tolerance [113]. Insulin resistance
has been implicated in the pathogenesis of several diseases, most notably, CVD [88] and
diabetes [114]. Routine exposure to high calorie, high-fat, high simple sugar meals may
impart adverse effects on metabolic function in such a way as to increase disease risk.
Dietary modification to favor lower calorie intake, devoid of SFA and processed food,
may be responsible for a reduction in disease risk.
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Cardiovascular Disease and Diabetes
The beta cells (β-cells) of the pancreas and endothelial cells of the vasculature are
unable to modulate substrate uptake like adipose and muscle tissue, and are therefore
exposed to hyperglycemic/hypertriglyceridemic states. The inability of β-cells and
endothelial cells to modulate substrate uptake leads to additional RONS production,
which ultimately promotes an increased risk for diabetic complications [114]. Studies
indicate that prolonged exposure to elevated glucose, FFA, or a combination of both, lead
to β-cell dysfunction and endothelial dysfunction [114]. The aforementioned state is
associated with an increase in ONOO--. Peroxynitrite is cytoxic because it oxidizes
sulfhydryl groups in proteins, initiates lipid peroxidation, and can disrupt many signal
transduction pathways [115]. The production of ONOO--, through the overproduction of
NO and O2•-, results in acute endothelial dysfunction, enhancing the risk for CVD [116].
In addition, it has been suggested that hyperglycemia activates several major biochemical
pathways that influence vascular complications including: advanced glycation end
products (AGEs) and receptors for AGE (RAGE) [117], protein kinase C (PKC), the
polyol pathway, and hexosamine pathways [118].
The β-cells of the pancreas have low levels of antioxidant enzymes that would
play a key role in scavenging RONS [119]. Therefore, an increase in oxidative damage
leads to impaired insulin production and secretion. The Common Soil Hypothesis is
based off of evidence that points towards oxidative stress as the “common” driving force
behind T2DM and CVD [87]. While oxidative stress is a common denominator in the
steps leading towards diabetes and CVD, it appears as though insulin resistance is one of
the initiating physiologic responses from oxidative stress that leads to the progression of
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disease. This can be inferred when looking at evidence that associates a
hyperglycemic/hypertriglyceridemic state with an insulin resistance response and the
subsequent effects on the endothelial and β-cells. These are all key characteristics in the
development of T2DM [114] and CVD [116].
Reducing Oxidative Stress
Pharmaceuticals
The link between oxidative stress, T2DM, the metabolic syndrome, and CVD is
widely accepted in the scientific community (reviewed in [120]). Additionally, recent
evidence indicates that many drugs used to treat symptoms of the metabolic syndrome
have strong intracellular antioxidant activity and can be used to attenuate oxidative stress.
These drugs include calcium channel blockers, glitazones, thiazolinediones, angiotensinconverting enzyme (ACE) inhibitors, statins, and angiotensin II type 1 receptor blockers
(reviewed in [87, 121]). A growing body of evidence suggests that oxidative stress is one
of the underlying factors in the pathogenesis of many diseases [88, 114, 122], therefore it
is of no surprise that the aforementioned drugs additionally treat disease by working on
pathways that influence the production of RONS [123].
Dietary Supplements
From a dietary supplement perspective, the effect of antioxidants on attenuating
oxidative stress is most widely investigated. Research indicates potential benefits from
micronutrients that are associated with natural products. Some of which include popular
antioxidant-rich foods such as fruits, vegetables, legumes, olive oil, red wine, green tea,
and nuts (reviewed in [124]). Supplements that include lycopene, beta-carotene, alphacarotene, bixin, lutein, and paprika carotenoids have been shown to lower oxidative stress
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[125]. Additionally, one study demonstrated vitamin C supplementation to be as
effective at enhancing serum TAC as strawberry and spinach consumption [126].
Supplemental vitamin C, vitamin E, and carotenoids appear to have the most benefits
with regards to their antioxidant effects, working synergistically to quench free-radicals
(reviewed in [127]). However, some studies fail to demonstrate a reduction in oxidative
stress biomarkers from antioxidant supplementation, leaving some to conclude
insufficient evidence (reviewed in [128]).
Exercise
It has been postulated that part of the beneficial effects of exercise are attributed
to the acute increase in RONS production; specifically RONS generated via intracellular
mitochondria [12]. The motive of such a claim comes from evidence that indicates
increases in RONS production and oxidative stress biomarkers during both acute aerobic
[129] and anaerobic [130] exercise. Based on the concept of hormesis/mitohormesis,
there is an optimal level of RONS production from exercise that is beneficial to health
[131]. Chronic exercise training and the repeated exposure of increased RONS
production leads to an increase in endogenous antioxidant activity, perhaps an adaptation
to protect during subsequent bouts of physical activity [132]. However, overtraining and
chronic high-intensity exercise is associated with a production of RONS that is
overwhelming to the antioxidant defense system, thereby resulting in oxidative damage
and increased risk for disease [133].
Nutrients
The consumption of food in the form of lipid [81, 82], carbohydrate [83], protein
[82], as well as a mixed meal [80] increases the production of RONS. The severity of
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oxidative insult can vary with regards to the subject population and the meal composition
used. For example, aging can influence RONS production (reviewed in [134]) and
insulin sensitivity [135], potentially leading to confounding findings following
macronutrient consumption.
The rise in TAG following lipid consumption seems to correlate with the degree
of oxidative stress observed in healthy individuals [136], with exacerbated responses
observed in diseased individuals [137]. In relation, there is evidence that demonstrates a
decrease in postprandial oxidative stress in patients with the metabolic syndrome,
following a high MUFA diet (20% fat from MUFA) when compared to a high SFA diet
and a low-fat/high carbohydrate diet [138].
Carbohydrate consumption (75g glucose tolerance test) in insulin resistant
individuals results in a significant elevation of oxidative stress, as measured by F2-IsoPs
[139]. However, increases in oxidative stress in healthy people following carbohydrate
ingestion do not occur [81, 140]. Protein, when compared to both lipid and carbohydrate
consumption, results in the lowest increase in O 2•- production [82]. Furthermore,
evidence indicates that when protein is added to a high-carbohydrate [141] and high-fat
meal [142], the result is a decrease in glycemia and lipemia; both of which cause
increases in RONS production [90].
Aside from macronutrients, an abundance of research has gone into understanding
the role of micronutrients on attenuating oxidative stress. In this regard, antioxidant
vitamins are most extensively studied and include: ascorbic acid (Vitamin C), tocopherol
(Vitamin E), and carotenoids. These exogenous antioxidants are obtained by
diet/supplementation and can play a role in the inhibition of oxidative damage
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Vitamin C can best be obtained from fruit and vegetable sources, as well as
supplements (drinks, pills, etc.). The antioxidant properties of vitamin C is characterized
by the ability to scavenge O2•-, H2O2, hypochlorite, OH•, ROO•, and singlet oxygen (O2)
(reviewed in [127]). Data indicate that vitamin C supplementation in smokers and nonsmokers may or may not decrease oxidative stress as measured by TBARS and MDA
[128]. However, large doses of vitamin C (2000 mg/day/) for five days in heavy smokers
(30+ cigarettes/day) resulted in a significant reduction in the urinary excretion of F2-IsoPs
[143]. This finding provides strong support for the antioxidant effects of vitamin C,
given that F2-IsoPs are considered to be one of the more reliable markers of oxidative
damage. In vitro trials have demonstrated a regenerating effect of vitamin C reducing the
tocopheroxyl radical back into the radical scavenging α-tocopherol molecule (reviewed in
[144]). In theory, this regenerative activity of vitamin C allows for the scavenging of
RONS into relatively unreactive products thus preventing oxidative damage. However,
in vivo studies have shown that acute intake of Vitamin C (500 mg) alone, or in
combination with Vitamin E (400 IU), has no protective effects on DNA damage or lipid
peroxidation in healthy individuals [145].
Vitamin E refers to a group of fat-soluble molecules, tocopherols and tocotrienols
(each of alpha, beta, gamma, and delta). The most biologically active form of Vitamin E
and the most extensively studied is α-tocopherol, which is abundant in wheat germ oil,
sunflower oil, safflower oil, nuts, and green leafy vegetables. The ability of α-tocopherol
to scavenge RONS and herby protect from lipid peroxidation is the hypothesized
antioxodiant mechanism. Vitamin E (280 mg/day for 10 weeks) has been shown to
significantly reduce lipid oxidative damage in smokers and non-smokers, as measured by
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TBARS [146]. Vitamin E supplementation in hypercholesterolemic patients at 600
mg/day for 14 days rather than 100 mg/d resulted in a reduction in lipid peroxidation
(measured by F2-IsoPs). In vivo data is lacking pertaining to the regeneration of Vitamin
E from the tocopheroxyl radical via reduction by ascorbate. However, it appears as
though Vitamin E mainly scavenges lipid ROO• to yield lipid hydroperoxides and a
tocopheroxyl radical, acting as a radical “chain breaker” in lipid peroxidation (reviewed
in [144]).
Carotenoids are organic pigmented compounds, responsible for the green, yellow,
red, and orange colors that are associated with the beneficial properties of fruits and
vegetables to prevent disease. Carotenoids of different structures can be found in many
fruits and vegetables including: carrots (alpha- and beta-carotene), tomatoes (lycopene),
citrus fruits (β-cryptoxanthin), spinach (lutein), and maize (zeaxanthin). These
phytochemicals are known to exert antioxidant effects by scavenging O2,
tricholromethyperoxyl radicals, and ROO •. Several in vitro and in vivo studies have
demonstrated the antioxidant properties of beta-carotene and lycopene, and there is a
growing body of evidence associated with lycopene and the reduction of disease risk
factors (reviewed in [147]). By acting as an antioxidant and reducing oxidative damage,
it seems reasonable that adequate consumption of carotenoids can help prevent the
progression of many diseases.
Evidence indicates that the consumption of a wide variety of micronutrients
associated with antioxidant properties could possibly be beneficial in attenuating
oxidative damage by up-regulating the antioxidant defense system. In addition to
oxidative stress, inflammation is also known to play a role in the pathogenesis of disease.
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Inflammation
Inflammation is initiated in the body as a response mechanism to certain stimuli.
The inflammatory response is associated with an increase in blood plasma and leukocytes
to an “injured area”, in an attempt to rid the body of foreign substances or repair damaged
cells [148]. One cause of inflammation in the body is the inability to modulate cellular
redox homeostasis, which has been demonstrated in the aging process [149]. As such,
aging has been associated with an increase in inflammation due to an age related
functional decrease in RONS scavenging antioxidant enzymes. A decline in the ability to
effectively respond to increased RONS production shifts the intracellular redox balance.
A shift in redox homeostasis initiates a cascade of inflammatory responses that is driven
by the activity of NF-κB; a redox sensitive transcription factor responsible for oxidative
damage induced inflammation (reviewed in [149]). In addition to aging, dietary intake
can affect the inflammatory response in the body, and this response has also been linked
to oxidative stress, insulin resistance, obesity, T2DM, and CVD [150].
Measuring Biomarkers of Inflammation
White blood cell count (WBC) is the most fundamental clinical measure of
inflammation, as it represents cells of the immune system that are responsible for fighting
infectious disease and foreign material. Studies have shown WBC to be a predictor of
decreased insulin sensitivity, as well as the development of T2DM [151], CHD, and CVD
[152]. However, with the growth of technology, and our understanding of disease, there
are a number of inflammatory molecules becoming prevalent in the pathogenesis of age
related diseases. Two of the more common methods used for measuring these
inflammatory molecules include the use of ELISA techniques and multiplex assays.
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Until recently, an ELISA format limited the analysis of a sample to one type of
protein/cytokine at a time (reviewed in [153]). Advances in ELISA technology has
allowed for multiple proteins to be measured within a single sample. This multiplex
ELISA procedure provides accurate and reproducible results, with improved sensitivity
and economy when compared to the single ELISA format [154].
The term cytokine is used to describe a large family of immunomodulating/cell
signaling protein molecules that play a role in intracellular communication. During
endothelial injury, cytokines act as signaling molecules that mediate the migration of
leukocytes, cause activation of the acute phase response, and initiate the release of
associated inflammatory mediators from the liver (reviewed in [155]). Inflammatory
cytokines such as Interleukin-6 (IL-6), IL-8, IL-1β, TNF-α, and CRP are some of the
main pro-inflammatory cytokines that initiate the response to a specific stressor/injury
[156].
The inflammatory molecules IL-6 and TNF-α, stimulate the synthesis of the acute
phase reactants which consists of CRP, amyloid-A, and fibrinongen [157]. While TNF-α
and IL-6 have been shown to be associated with recurrent [158] and future [159]
coronary events respectively, CRP has been identified as the most reliable assessment of
inflammation in clinical practice [48, 160]. C-reactive protein is an early acute phase
reactant that responds to active infection and acute inflammation. Recently reviewed in
[156], CRP has been shown to correlate most strongly with obesity/visceral fat
deposition, but additional studies have shown correlations with markers of insulin
sensitivity, TAG, and HDL-C. C-reactive protein < 1, 1-3, and > 3 mg/L, corresponds to
low, moderate, and high CVD risks [161]. Traditional assays of CRP were not sensitive
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enough to monitor changes in chronic inflammation, and therefore, the development of
high-sensitivity CRP assays have made detection of chronic inflammation possible [162].
Implications for Health and Disease
It is widely accepted that obesity, among other environmental factors, is linked to
diseases such as hypertension, CVD, dyslipidemia, and T2DM [163]. Mechanisms that
relate the pathogenesis of these diseases to obesity are still being elucidated, however, an
increase in inflammation is a common feature of many age related chronic diseases
[163]. Elevation of the pro-inflammatory molecule TNF-α has been shown to play a role
in systemic insulin resistance by interfering with receptor signaling [164]; a potential link
between obesity, insulin resistance, and diabetes. Moreover, TNF-α has been shown to
be an independent predictor in CHD and CVD events and total mortality among men
[165].
Inflammation has been shown to play a role in pathways involving insulin
mediated responses [164, 166]. It has been postulated that exposure to a fat-rich diet
causes an increase in inflammation in the hypothalamic area involved with leptin and
insulin signaling, leading to impaired control of food intake and energy expenditure
(reviewed in [166]). Other data demonstrates similar mechanistic actions, as seen from
the effects of TNF-α mediated disturbances in insulin signaling pathways of myocytes
and brown adipocytes [167]. These data demonstrate the correlation of inflammation
with all of the following variables; obesity, local inflammatory mediators, insulin
resistance, CVD, and T2DM. Even more, recent work has indicated that chronic
inflammation with elevated serum concentrations of TNF-α, IL-1, IL-6, and CRP are
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associated with the progression from normolycemia to insulin resistance [168, 169]—
important factors in the development of T2DM and CVD [150].
Interluekin-6, which is also linked with the development of insulin resistance, as
well as future cardiovascular events, is released by adipose tissue and acts as a mediator
of inflammation [170, 171]. Additionally, studies have shown that older sedentary adults
have higher levels of TNF-α, CRP, and IL-6 compared to age-matched active individuals
[172]. Moreover, CRP has been found to be an independent predictor of cardiovascular
events [160]. A recent review indicates that CRP is not only a biomarker in the
development of atherosclerosis, but according to in vitro findings, CRP is involved in the
pathogenesis through a number of mechanisms (reviewed in [156]).
In accordance, the molecular inflammation hypothesis of aging associates age
related obesity (specifically greater visceral fat) with increased systemic inflammation.
As mentioned previously, and reviewed in [149], there is an age associated decrease in
antioxidant defense enzymes and this further underlies the inflammatory process,
specifically due to a lack of control over redox homeostasis. This unresolved low-grade
systemic inflammation is believed to be the culprit for many age related diseases, such as,
CVD, cancer, diabetes, metabolic syndrome, dementia, osteoporosis, and arthritis
(reviewed in [134]). These data presented are strong evidence for the role that
inflammation plays in aging as well as its implications for health and disease. With that
said, reducing inflammation would be ideal for optimal health, and this will be discussed
in the next section.
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Reducing Inflammation
Pharmaceuticals
There is a growing body of evidence indicating that statins not only act as lipid
lowering drugs, but they also act in an anti-inflammatory manner that is lipidindependent (reviewed in [173]). Studies have shown that the use of statins
(cerivastatin—0.4 or 0.8 mg/day for 8 weeks) results in a 24.5% reduction in mean CRP
levels [174]. Others have noted decreases in CRP up to 37% in healthy individuals (CRP
> 2.0 mg/L) following treatment with rosuvastatin [175]. Metformin is used as first-line
therapy for the treatment of T2DM, and has been shown to reduce CRP by 7 and 14% in
men and women with impaired glucose tolerance [176], and by 26% in individuals
recently diagnosed with T2DM [177]. An investigation by Kahn et al demonstrated a >
40% reduction in CRP within 6 months of treatment with rosiglitazone in diabetics [177].
Rosiglitazone is in the thiazolinedione class of drugs, which are known for their insulin
sensitizing effects. Additionally, thiazolinediones have been shown to reduce
inflammation in a mechanism that is independent of their effects on glycemic control
[178]. While drugs have shown efficacy in reducing inflammation, an increasing interest
in dietary supplements has led investigators to study if and how these supplements affect
inflammation.
Dietary Supplements
Outside of pharmacological therapy, the use of nutraceuticals and phytochemicals
(chemical compounds in plants) has been extensively studied and has revealed promising
results in their abilities to reduce inflammation (reviewed in [179]). Phytochemicals,
mostly flavones and flavonols, have shown to possess anti-inflammatory effects by

65

inhibiting TNF-α gene expression and inhibiting NFκB activity [180]. Supplementing
fish oil that is rich in omega-3 PUFAs for 12 week has been shown to significantly
reduce plasma TNF-α in healthy males and females [181]. However, a recent metaanalysis indicated no effects from fish-oil supplementation on markers of CRP and TNFα [182]. Curcuma longa, which is commonly referred to as turmeric, exerts its antiinflammatory effects by reversing insulin resistance, hyperglycemia, hyperlipidemia, and
other symptoms linked to inflammation (reviewed in [183]). Additionally, in vitro
studies have demonstrated the ability of curcumin to decrease the expression of
inflammatory cytokines IL-6, IL-1β, and TNF-α [184]. A recent review by Aggarwal
(2010) describes other spice nutraceuticals that have demonstrated the ability to modulate
inflammatory pathways including: capsaicin, gingerol, cinnamaldehyde, piperine, and
fenugreek [183]. While there are many prospective supplements/nutraceuticals
associated with anti-inflammatory benefits, the majority of this evidence stems from
animal and in vitro studies [179]. With more research and a greater understanding of
these molecules in vivo, the use of these supplements/nutraceuticals could prove to be
efficacious for the treatment of many inflammatory- related diseases.
Exercise
Obese individuals are at higher risks for developing cardiovascular related
diseases, partly because of an increase in systemic inflammation [185]. Cross-sectional
studies indicate an association between physical inactivity and systemic inflammation in
healthy middle-aged and older adults in the United States [186]. Evidence indicates that
exercise would benefit this population due to the associated anti-inflammatory effects
seen with chronic exercise (reviewed in [150]). It has been proposed that exercise
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induced pro-inflammatory cytokines triggers the up-regulation of anti-inflammatory
cytokines following exercise [187]. Individuals at risk for ischemic heart disease who
engage in a variety of exercises (2.5 hours/week) for six months show a significant
reduction in the pro-inflammatory cytokine TNF-α as well as a 35% reduction in CRP
[188]. A cross-sectional study by Colbert et al (2004) indicated that higher levels of
exercise are associated with lower levels of CRP, TNF-α, and IL-6 [172]. While exercise
has been investigated as an option for reducing inflammation, investigations involving
nutrient intake is as important, if not more important.
Nutrients
Evidence indicates that long chain SFAs contribute to inflammation through a
variety of mechanisms. One hypothesis associates a fat-rich diet, specifically SFAs
[189], with an impaired ability to modulate leptin and insulin signaling in the
hypothalamus. This hypothesis is based off of studies that demonstrates SFA induced
inflammatory damage to local networks of neurons in the hypothalamus, leading to an
impaired ability to modulate energy homeostasis and the development of obesity
(reviewed in [166]). An investigation by Arya et al (2006) indicated that SFAs were the
most important nutrient that contributed to increases in CRP in healthy adolescents and
young adults [190]. It was also noted that for every 1% decrease in calories of SFA
consumed, a decrease in serum CRP by 0.14 mg/L was shown [190].
A recent review of literature indicates that there is a lower risk in the development
of inflammatory related diseases with a lower omega-6/omega-3 fatty acid ratio intake
[191]. PUFA intake, specifically omega-3 PUFA, has been shown to inversely correlate
with plasma levels of soluble TNF receptors, as well as CRP, albeit to a lesser degree (p
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= 0.08). These associations were demonstrated in the omega-3 PUFAs, Eicosapentaenoic
acid (EPA) and Docosahexaenoic acid (DHA), but not α-Linolenic acid (ALA)—
commonly found in vegetable oils [192]. The dietary intake of MUFAs has been shown
to be inversely associated with plasma CRP and IL-6 in healthy middle aged men and
women [193]. These findings are in line with other data, in which a high MUFA diet (>
20% total fat) significantly reduced IL-6 and CRP in young overweight men and women
(average age of 28 years) [194]. It appears as though one could favorably alter
inflammation, specifically CRP, IL-6, and TNF-α, if one were to increase MUFA intake,
decreases SFA intake, and consume a lower omega-6/omega-3 fatty acid ratio.
The LIPGENE study investigated the effects of a 12 week dietary intervention on
CRP and F2-isoPs in 486 volunteers with the metabolic syndrome. This study included
four separate dietary approaches: two high-fat diets (38% energy), one rich in SFA and
one in MUFA, and two low-fat high complex carbohydrate diets, one supplemented with
omega-3 fatty acids and one with oleic acid. Interestingly, this study found no significant
differences in pre- and post-intervention values of CRP and F2-isoPs [195]. A recent
investigation by Johnstone et al (2011) was a well-controlled, randomized, cross-over
design study in obese men and women that compared a 4-week low carbohydrate diet
rich in MUFA (30% protein, 4% carbohydrate, and 66% fat) versus a 4-week moderate
carbohydrate diet (30% protein, 35% carbohydrate, and 35% fat). The study noted a
significant reduction in TNF-α and IL-10 in both groups. Also, the moderate
carbohydrate diet decreased IL-10 concentrations significantly more than the lowcarbohydrate diet [196]. Regarding carbohydrate type (i.e. high versus low glycemic), a
low glycemic index diet is associated with a lower concentration of CRP when compared
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to a high glycemic index diet [197]. In addition, studies have demonstrated a significant
reduction in CRP when obese men and women consume a 12-week hypocaloric diet in
which all of their grains are derived from whole grains [198].
A 52-week energy restricted/high-protein diet (30% energy) has been shown to
significantly reduce CRP levels in obese individuals with hyperinsulinemia [199], which
is in line with other findings [200, 201]. Protein in the form of soy and soy isoflavones
have been shown to have little effect on CRP, TNF-α, and IL-6 (reviewed in [202]).
However, there is also data that demonstrate beneficial effects of soy products on
inflammation following 8 weeks of soy-based nutritional supplementation. This was
demonstrated in end-stage renal disease patients on hemodialysis by the inverse
relationship of total blood isoflavones and CRP, and a ~47% reduction in CRP. It is
noteworthy that the CRP levels in the subjects were high (median 18.2 mg/L);
nonetheless, the anti-inflammatory effects of isoflavones appeared to benefit this
population [203].
A recent cross-sectional study on the relationship between dietary intake and
inflammatory markers in young boys and girls indicated no relationship between total
flavonoid intake and markers of CRP, IL-6, and TNF- α. However, total fruit and
vegetable intake was significantly and inversely correlated with CRP, IL-6, and TNF-α—
CRP was inversely associated with intakes of fruit and vitamin C, TNF-α was inversely
associated with carotene, and IL-6 was inversely associated with intakes of legumes,
vegetables, beta-carotene, and vitamin C [204]. This study indicates the beneficial
effects of fruit and vegetable intake at a young age. Furthermore, the acute intake of
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Vitamin C (1g) and Vitamin E (800 IU) has been shown to significantly reduce the meal
induced rise in CRP in T2DM patients following a fat-rich calorie dense meal [205].
C-reactive protein was significantly reduced following 2 weeks of a high TAC
diet versus a low TAC diet in healthy men and women. Also, during the high TAC diet,
intake of Vitamin C and E were significantly higher [206]. However, other data does not
support this association [207]. It is noteworthy to mention that the former study [206]
was specifically comparing the effects of two different diets on biomarkers of
inflammation, while the later [207] was a cross-sectional study that measured the
correlation between the dietary intake of micronutrients and inflammation. One
interesting finding from the investigation of de Oliveira et al (2011), was that a higher
intake of heme-iron was positively associated with plasma CRP concentrations [207].
While animal products are common sources of heme-iron, this association was
independent of red meat, poultry, and fish, and was likely attributed to a combination of
the three. Other cross-sectional studies have found that as the consumption of red-meat
increases, so too does dietary iron, plasma CRP, and the risk of metabolic syndrome
[208].
The Daniel Fast, which is characteristically a high TAC diet devoid of animal
products and lower in protein as compared to traditional diets [1, 2], has been shown to
reduce CRP from 3.15 to 1.6 mg/L in 21 days (~49%) [1]. Although this reduction was
not statistically significant, it could prove to have clinical relevance. Furthermore, the
Daniel Fast promotes the consumption of fruits, vegetables, and whole grain products, all
of which constitute that of a vegetarian diet and are emphasized in a recent expert panel
on vegetarian nutrition [209].
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Daniel Fast
The Daniel Fast is a Christian based fast that has been derived from biblical text.
The Daniel Fast is commonly practiced at the turn of a New Year; however one may
partake in the fast at any time. In Daniel 1:8-14, Daniel asked the chief official for
permission to have only vegetables to eat (or pulse in some translations, which means
“food grown from seed”) and water to drink, instead of the royal food and wine. In
Daniel 10:2-3, Daniel refrained from choice foods for 21 days, which coincided with a
period of mourning. From these two passages, a modern-day Daniel Fast has been
developed and can be described as a form of DR and a variation of veganism. The Daniel
Fast allows for the ad libitum consumption of fruits, vegetables, whole grains, nuts,
seeds, legumes, and oil. Animal products, refined foods, white flour, preservatives,
additives, sweeteners, flavorings, caffeine, and alcohol are prohibited during this fast.
The Daniel Fast, like many plant-based diets [210], has demonstrated favorable
outcomes on blood lipids [1]. A 21-day Daniel Fast is associated with significant
reductions in TC, LDL-C, and HDL-C [1]. The TC/HDL-C ratio, TAG, and VLDL-C
did not change during this intervention. However, recently completed unpublished work
with the Daniel Fast has demonstrated a reduction in the LDL-C/HDL-C ratio and
TC/HDL-C ratio, in addition to similar findings for the other blood lipids. While the
reductions in blood lipids in just 21 days are favorable, the fast is also associated with a
decrease in HDL-C, which is unfavorable from a cardio-protective standpoint.
Reductions in HDL-C are common in low-fat vegetarian diets, but this reduction is not
associated with poor cardiovascular health (reviewed in [210]). The latter statement is
relevant to the Daniel Fast as well, due to the striking similarities between the two diets.
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A 21-day Daniel Fast has also been shown to significantly reduce markers of
oxidative stress and increase antioxidant capacity in healthy men and women (35 ± 1
years of age), as measured by MDA and TEAC respectively [2]. Additionally, this
investigation noted a trend for the lowering of H2O2. However, recent unpublished data
from a 21-day Daniel Fast did not corroborate this finding, as there was no significant
reduction in MDA in healthy men and women (33.9 ± 2.1 years of age) with low baseline
levels of MDA. Regarding inflammation, there was a trend for lower CRP levels (~40%
reduction), as well as a significant reduction in the white blood cell count [1].
Another plausible explanation for the benefits associated with the Daniel Fast
could be due to the effects of protein restriction (as well as the SFA that coincides with
consumption of certain animal proteins), as protein consumption has been shown to
significantly decrease during times of fasting [2]. Additionally, MR may account for a
large portion of the benefits observed with the Daniel Fast due to the abstinence of meat
from the diet and the relatively low methionine content of a plant based diet [23].
However, the strictness of a Daniel Fast diet may make compliance and sustainability
difficult if adopted for a long period of time. Therefore, including a small amount of
animal products may be reasonable, in particular if such inclusion does not adversely
impact the positive findings in a significant way. Indeed, evidence indicates that
moderate amounts of lean meat are beneficial to total nutritional intake and can still be
used to adequately reduce blood cholesterol, albeit to a lesser extent than a pure
vegetarian diet [211, 212]. Moreover, the addition of some animal protein may allow for
maintenance of HDL-C [213-215]. If so, such maintenance of this cholesterol fraction
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might offset any untoward effect that the animal protein may have on other health-related
biomarkers.
Our prior work with the Daniel Fast has generated many favorable results. As it
appears, many of the other aforementioned dietary regimens provide a certain degree of
health-related benefits as well. However, it goes without saying that many people have
had trouble adopting these dietary regimens and incorporating them into their everyday
life. The ad libitum nature of the Daniel Fast makes it a good candidate for dietary
adherence. Prior investigations with the Daniel Fast have noted a greater than 95%
compliance rate [1, 2]; however these studies only lasted three weeks. Based on subject
comments, long-term compliance without animal protein may not be high, and therefore a
modified approach must be considered for long-term compliance. However, before
incorporating a long-term diet with unknown effects, we first must ensure that this
modified approach can produce similar results as those seen in a traditional 21-day
Daniel Fast.
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APPENDIX C
DANIEL FAST QUESTIONNAIRE
Please answer the following questions as accurately and honestly as possible. Provide as
much detail as you feel necessary. Upon completion, a research assistant will review your
responses with you in order to provide clarification where necessary.

1. Please rate your compliance to the fast as a percentage (0-100%) based on food
choices, use of additives, preservatives, flavorings, caffeine, etc. Provide any
necessary remarks for us to better understand reasons behind your compliance.
Were there one or two items in particular that lead to your non-compliance, if this
was the case?

2. Please rate your overall mental outlook and mood during the period of the fast
on a scale of 1-10 (1 = as low as possible; 10 = as high as possible). Were there
any outside influences that factored into your overall mood or can you accurately
state that your mood was influenced primarily by the fast?

3. Please rate your overall physical health and vitality during the period of the fast
on a scale of 1-10 (1 = as low as possible; 10 = as high as possible). Were there
any outside influences that factored into your overall physical health and vitality
or can you accurately state that your physical health and vitality was influenced
primarily by the fast?

4. Please rate your overall level of satiety (feeling of fullness in relation to food
intake) during the period of the fast on a scale of 1-10 (1 = as low as possible; 10
= as high as possible).
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APPENDIX D
INSTITUTIONAL REVIEW BOARD APPROVAL
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